A0_Samples A1_OS A2_Event A3_T A4_N A5_M A6_Stage A8_New_Event A8_New_Event_Time A8_New_Event_Tissue A8_New_Event_Type additional_studies age_at_initial_pathologic_diagnosis anatomic_neoplasm_subdivision bcr_patient_barcode bcr_patient_uuid braf_gene_analysis_performed braf_gene_analysis_result circumferential_resection_margin colon_polyps_present day_of_form_completion days_to_birth days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_last_known_alive drugs.drug.bcr_drug_barcode drugs.drug.bcr_drug_uuid drugs.drug.clinical_trail_drug_classification drugs.drug.day_of_form_completion drugs.drug.days_to_drug_therapy_end drugs.drug.days_to_drug_therapy_start drugs.drug.drug_name drugs.drug.measure_of_response drugs.drug.month_of_form_completion drugs.drug.number_cycles drugs.drug.prescribed_dose drugs.drug.prescribed_dose_units drugs.drug.regimen_indication drugs.drug.regimen_indication_notes drugs.drug.regimen_number drugs.drug.route_of_administrations.route_of_administration drugs.drug.therapy_ongoing drugs.drug.therapy_types.therapy_type drugs.drug.therapy_types.therapy_type_notes drugs.drug.total_dose drugs.drug.total_dose_units drugs.drug.tx_on_clinical_trial drugs.drug.year_of_form_completion ethnicity follow_ups.follow_up.bcr_followup_barcode follow_ups.follow_up.bcr_followup_uuid follow_ups.follow_up.day_of_form_completion follow_ups.follow_up.days_to_death follow_ups.follow_up.days_to_last_followup follow_ups.follow_up.followup_case_report_form_submission_reason follow_ups.follow_up.followup_treatment_success follow_ups.follow_up.lost_follow_up follow_ups.follow_up.month_of_form_completion follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_radiation_therapy follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_type follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure follow_ups.follow_up.new_tumor_events.new_tumor_event.residual_disease_post_new_tumor_event_margin_status follow_ups.follow_up.new_tumor_events.new_tumor_event.site_of_additional_surgery_new_tumor_event_mets follow_ups.follow_up.new_tumor_events.new_tumor_event_after_initial_treatment follow_ups.follow_up.person_neoplasm_cancer_status follow_ups.follow_up.postoperative_rx_tx follow_ups.follow_up.primary_therapy_outcome_success follow_ups.follow_up.radiation_therapy follow_ups.follow_up.vital_status follow_ups.follow_up.year_of_form_completion gender height histological_type history_of_colon_polyps history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified kras_gene_analysis_performed kras_mutation_codon kras_mutation_found loss_expression_of_mismatch_repair_proteins_by_ihc loss_expression_of_mismatch_repair_proteins_by_ihc_results.loss_expression_of_mismatch_repair_proteins_by_ihc_result lymph_node_examined_count lymphatic_invasion microsatellite_instability month_of_form_completion new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy new_tumor_events.new_tumor_event.additional_radiation_therapy new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment new_tumor_events.new_tumor_event.new_neoplasm_event_type new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure new_tumor_events.new_tumor_event.residual_disease_post_new_tumor_event_margin_status new_tumor_events.new_tumor_event.site_of_additional_surgery_new_tumor_event_mets new_tumor_events.new_tumor_event_after_initial_treatment non_nodal_tumor_deposits number_of_abnormal_loci number_of_first_degree_relatives_with_cancer_diagnosis number_of_loci_tested number_of_lymphnodes_positive_by_he number_of_lymphnodes_positive_by_ihc other_dx patient_id perineural_invasion_present person_neoplasm_cancer_status postoperative_rx_tx preoperative_pretreatment_cea_level primary_lymph_node_presentation_assessment primary_therapy_outcome_success race_list.race radiation_therapy radiations.radiation.anatomic_treatment_site radiations.radiation.bcr_radiation_barcode radiations.radiation.bcr_radiation_uuid radiations.radiation.course_number radiations.radiation.day_of_form_completion radiations.radiation.days_to_radiation_therapy_end radiations.radiation.days_to_radiation_therapy_start radiations.radiation.measure_of_response radiations.radiation.month_of_form_completion radiations.radiation.numfractions radiations.radiation.radiation_dosage radiations.radiation.radiation_treatment_ongoing radiations.radiation.radiation_type radiations.radiation.radiation_type_notes radiations.radiation.regimen_indication radiations.radiation.regimen_indication_notes radiations.radiation.units radiations.radiation.year_of_form_completion residual_tumor stage_event.ann_arbor.b_symptoms stage_event.ann_arbor.extranodal_involvement stage_event.clinical_stage stage_event.gleason_grading.gleason_score stage_event.gleason_grading.primary_pattern stage_event.gleason_grading.secondary_pattern stage_event.gleason_grading.tertiary_pattern stage_event.igcccg_stage stage_event.masaoka_stage stage_event.pathologic_stage stage_event.psa.days_to_psa stage_event.psa.psa_value stage_event.serum_markers stage_event.system_version stage_event.tnm_categories.clinical_categories.clinical_M stage_event.tnm_categories.clinical_categories.clinical_N stage_event.tnm_categories.clinical_categories.clinical_T stage_event.tnm_categories.pathologic_categories.pathologic_M stage_event.tnm_categories.pathologic_categories.pathologic_N stage_event.tnm_categories.pathologic_categories.pathologic_T synchronous_colon_cancer_present tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_tissue_site venous_invasion vital_status weight year_of_form_completion year_of_initial_pathologic_diagnosis TCGA-DC-6681 790 Alive T3 N2a M1a Stage IVA 0 790 70 Rectosigmoid Junction TCGA-DC-6681 3e97286f-8aa8-4b6a-b339-d7a8e30f60c2 YES Normal 15 NO Not Available -25659 Not Applicable 0 181 Not Available TCGA-DC-6681-D17003;TCGA-DC-6681-D17004;TCGA-DC-6681-D17001;TCGA-DC-6681-D17005 70773b35-24f4-40be-8d08-4e29f9b40993;db7f6761-c134-48ba-b2f3-df57a979b4b1;0389e5fe-ae72-4684-8857-a1786571f0fc;f49b8f63-3f14-47e6-ac92-e3fe637e5299 Not Available;Not Available;Not Available;Not Available 29;29;29;29 136;136;136;136 38;38;38;38 fluorouracil;Leucovorin Calcium;Fluorouracil;Oxaliplatin Not Available;Not Available;Not Available;Not Available 9;9;9;9 8;8;8;8 1900;160;600;110 mg;mg;mg;mg ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable;Not Applicable 1;1;1;1 IV;IV;IV;IV NO;NO;NO;NO Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy Not Available;Ancillary;Not Available;Not Available 15200;1280;3920;850 mg;mg;mg;mg Not Available;Not Available;Not Available;Not Available 2011;2011;2011;2011 NOT HISPANIC OR LATINO TCGA-DC-6681-F15645;TCGA-DC-6681-F30874;TCGA-DC-6681-F44768 7b430910-c285-49df-a62f-c051525a7edb;3708e8da-af41-4b95-a021-6f4905c95963;13C09BEB-2E53-4E36-BE53-633C6FBD9291 Not Available;18;26 Not Applicable;Not Applicable;Not Applicable 181;394;790 Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available;Not Applicable Not Available;Not Available;NO 8;4;6 NO;NO;NO TUMOR FREE;TUMOR FREE;TUMOR FREE YES;YES;YES Not Available;Not Available;Not Applicable NO;NO;NO Alive;Alive;Alive 2011;2012;2013 FEMALE 151 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES YES 12 YES NO Not Available 24 YES Not Available 8 Not Available NO Not Available 0 Not Available 7 Not Available No 6681 YES TUMOR FREE Not Available 7.9 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IVA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M1a N2a T3 NO YES NO DC Rectum YES Alive 63.1 2011 2011 TCGA-AG-4007 31 Alive T4 N2 M1 Stage IV 0 31 87 Rectum TCGA-AG-4007 8e00e7e7-ffaf-44f0-91a7-172671f18e08 NO Not Available 2 Not Available 18 -31776 Not Applicable 0 31 Not Available Not Available MALE Not Available Rectal Adenocarcinoma NO No C18.9 8140/3 C18.9 YES NO Not Available Not Available NO Not Available 34 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 5 Not Available No 4007 Not Available WITH TUMOR Not Available 3.65 YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M1 N2 T4 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AG-3732 1003 Alive T2 N0 M0 Stage I 0 1003 78 Rectum TCGA-AG-3732 a83923fd-276c-4526-9922-5ef741f551fd NO Not Available Not Available Not Available 18 -28521 Not Applicable 0 0 Not Available TCGA-AG-3732-D37646;TCGA-AG-3732-D37647 E3DA3054-7188-4C70-B09A-AAE3757CB1F5;F553079B-0B3B-485C-A8D3-B2D83729DB97 n/a;n/a 5;5 1673;1673 1277;1277 Capecitabine;Bevacizumab Unknown;Unknown 12;12 Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Applicable;Not Applicable Not Available;Not Available Not Available;Not Available NO;NO Chemotherapy;Targeted Molecular therapy Not Available;Not Available Not Available;Not Available Not Available;Not Available NO;NO 2012;2012 Not Available TCGA-AG-3732-F38011 7FD58A13-0001-4312-9E34-59AFD13434C0 8 Not Applicable 1003 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available Not Available Not Available 12 YES Not Available 5 Not Available Not Available Not Available 1 Not Available 0 Not Available No 3732 Not Available WITH TUMOR Not Available 1.21 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum NO Alive Not Available 2010 2005 TCGA-AF-3911 1148 Alive T3 N2 MX Stage IIIC 1 695.0 Not Available Unknown 48 Rectum TCGA-AF-3911 17e286b7-7793-446d-b556-1108addb5ba2 NO Not Available Not Available YES 28 -17609 Not Applicable 0 537 Not Available TCGA-AF-3911-D13481;TCGA-AF-3911-D13480;TCGA-AF-3911-D13478;TCGA-AF-3911-D13479;TCGA-AF-3911-D13456 ac0aeb25-48f3-4491-a888-09bc7cd2757f;763988bf-65bc-4af6-affa-2d62417e581e;9cf10576-9771-4a03-ab78-4c2dc302073e;378a1cdd-b199-4005-b5a8-590fe60c777c;93f15563-e1f4-4df9-98fe-2c058fa1aef0 Not Available;Not Available;Not Available;Not Available;Not Available 28;28;28;28;18 302;300;285;300;106 145;145;145;145;68 5FU;Leucovorin;Oxaliplatin;5FU;5FU Not Available;Not Available;Not Available;Not Available;Not Available 6;6;6;6;7 12;12;11;12;6 5112-5160;50-850;137-183;852-860;468-477 mg;mg;mg;mg;mg ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable 2;2;2;2;1 IV;IV;IV;IV;IV NO;NO;NO;NO;NO Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available;Not Available;Not Available 61776;6200;1868;10296;13271 mg;mg;mg;mg;mg Not Available;Not Available;Not Available;Not Available;Not Available 2011;2011;2011;2011;2011 NOT HISPANIC OR LATINO TCGA-AF-3911-F13443;TCGA-AF-3911-F19776;TCGA-AF-3911-F39018 c4b40609-531d-4459-a0f4-079e608d5454;117414aa-a9d8-4041-ae93-d60a07ad24f3;7E2DAE1D-5040-4D17-B55D-9F67D65FF61C 28;27;11 Not Applicable;Not Applicable;Not Applicable 537;761;1148 Scheduled Follow-up Submission;Additional New Tumor Event;Scheduled Follow-up Submission Not Available;Not Available;Progressive Disease Not Available;Not Available;NO 6;12;1 None;YES;NO None;NO;NO None;Not Available;Not Available None;695;1020 None;Unknown;Unknown None;NO;NO None;Not Available;Not Available None;Not Available;Not Available NO;YES;YES TUMOR FREE;WITH TUMOR;WITH TUMOR YES;Not Available;YES Not Available;Not Available;Complete Remission/Response YES;Not Available;YES Alive;Alive;Alive 2011;2011;2013 MALE 180.3 Rectal Adenocarcinoma Not Available No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 18 YES NO 6 Not Available YES 0 0 5 9 Not Available No 3911 Not Available TUMOR FREE Not Available 1.1 YES Not Available WHITE Not Available Primary Tumor Field TCGA-AF-3911-R13453 f7c39be5-5c87-4c65-9eec-8b4e30cee14a 1 28 107 68 Not Available 6 28 5040 NO EXTERNAL BEAM Not Applicable ADJUVANT Not Available cGy 2011 Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable MX N2 T3 NO YES NO AF Rectum NO Alive 94.5 2011 2009 TCGA-AG-3728 912 Alive T3 N1 M0 Stage IIIB 0 912 73 Rectum TCGA-AG-3728 856a490c-c6da-48fe-88b5-9fde0f481365 NO Not Available 10 Not Available 18 -26906 Not Applicable 0 0 Not Available TCGA-AG-3728-D37639;TCGA-AG-3728-D37640;TCGA-AG-3728-D37641 53588706-BC6B-405C-A6D2-4C7953641320;73B9ADC4-8BF1-4085-B885-844051A7F688;294E64A4-AE56-42C8-A708-559C0DD9689A n/a;n/a;n/a 5;5;5 61;61;61 61;61;61 Folinic acid;5-Fluorouracil;Oxaliplatin Complete Response;Complete Response;Complete Response 12;12;12 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2012;2012;2012 Not Available TCGA-AG-3728-F38295 577CD483-0C80-4A1F-BAB7-67274F2CB012 12 Not Applicable 912 Scheduled Follow-up Submission Unknown NO 12 Unknown Unknown YES Complete Remission/Response NO Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 19 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 3 Not Available No 3728 Not Available WITH TUMOR Not Available 1.89 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T3 YES NO YES AG Rectum NO Alive Not Available 2010 2006 TCGA-G5-6233 556 Dead T3 N2 M0 1 92.0 Not Available Unknown 74 Sigmoid Colon TCGA-G5-6233 ff427104-0727-483c-8513-243dec80db9d NO Not Available Not Available NO 14 -27190 556 0 Not Available Not Available TCGA-G5-6233-D21974;TCGA-G5-6233-D21976;TCGA-G5-6233-D21971 5646f05f-fd36-42e5-8ff3-7e36ff7ad118;de57c88f-e829-4be0-8365-eee4b531dd1d;8151e8a5-d1e3-4f9f-b00c-c87ca2e13f6b Not Available;Not Available;Not Available 6;6;6 270;270;270 117;117;117 Fluorouracil;Leucovorin;Oxaliplatin Not Available;Not Available;Not Available 2;2;2 9;9;9 Not Available;Not Available;Not Available Not Available;Not Available;Not Available PROGRESSION;PROGRESSION;PROGRESSION Not Applicable;Not Applicable;Not Applicable 1;1;1 Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available 2012;2012;2012 NOT HISPANIC OR LATINO TCGA-G5-6233-F21970 5c011f74-6014-40d4-a124-169001c5d838 3 556 Not Available Scheduled Follow-up Submission Not Available Not Available 2 YES NO Not Available 92 Unknown NO Not Available Not Available YES WITH TUMOR NO Not Available NO Dead 2012 MALE 176.9 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES YES 12 YES NO Not Available 72 YES Not Available 7 Not Available YES Not Available 0 Not Available 27 Not Available Yes 6233 YES WITH TUMOR Not Available 0.5 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Discrepancy Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N2 T3 NO NO YES G5 Rectum YES Dead 97.7 2011 2009 TCGA-EI-6884 328 Alive T3 N1 M0 Stage IIIA 0 328 71 Rectosigmoid Junction TCGA-EI-6884 b2b125c7-8993-4424-b390-048ccccc9d08 NO Not Available Not Available NO 18 -25995 Not Applicable 0 83 Not Available TCGA-EI-6884-D29853 36a71370-2d4f-45ac-8144-14a8731a5ce6 Not Available 30 Not Available 52 5 fluorouracilum+leucovorin Not Available 3 Not Available Not Available mg/kg ADJUVANT Not Applicable Not Available IV YES Chemotherapy Not Available Not Available mg Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-6884-F29854 53bb0172-842b-4f3c-85b4-12fa8993d34c 30 Not Applicable 328 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE YES Not Available NO Alive 2012 MALE 166 Rectal Adenocarcinoma NO No C20 8211/3 C20.9 YES NO Not Available Not Available NO Not Available 8 NO NO 7 Not Available NO Not Available 0 Not Available 3 Not Available No 6884 NO TUMOR FREE Not Available 10.7 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO YES NO EI Rectum NO Alive 73 2011 2011 TCGA-AG-A002 638 Alive T2 N0 M0 Stage I 0 638 35 Rectum TCGA-AG-A002 cb005c69-7301-41ce-b534-c9751f1436c5 NO Not Available Not Available Not Available 15 -13090 Not Applicable 0 31 Not Available Not Available TCGA-AG-A002-F38304 E0E9D11D-F3C1-41AF-A770-76308215647B 12 Not Applicable 638 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Complete Remission/Response NO Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 34 Not Available Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available No A002 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum Not Available Alive Not Available 2011 2009 TCGA-DC-6156 943 Alive T4a N2b M1a Stage IVA 1 30.0 Not Available Unknown 62 Rectosigmoid Junction TCGA-DC-6156 261925e3-96e4-440c-8e95-c003d44ab2f2 NO Not Available 5 NO 26 -22706 Not Applicable 0 212 Not Available TCGA-DC-6156-D15198;TCGA-DC-6156-D15196;TCGA-DC-6156-D15197;TCGA-DC-6156-D15199;TCGA-DC-6156-D21979;TCGA-DC-6156-D21980;TCGA-DC-6156-D29374;TCGA-DC-6156-D29373;TCGA-DC-6156-D29375;TCGA-DC-6156-D44758 c3baaf92-b499-4f7a-9431-70b545c0e8d3;60a99194-92a3-4737-a849-330f061aa523;f501c115-db91-4cde-acb1-35d17cf23bed;609c5cb0-e725-45d6-991d-6064fdca9e45;d409689c-b0f7-406a-bb0d-f9f1dc4b774f;54129ecf-0125-45a8-8506-eb8248500ae8;f4c74905-0f74-43ef-993d-bf84e70f61c1;7924ad55-eb1c-47f3-a2b5-aefe07edff8d;e8158296-a375-4c50-a27d-a7021b3a07d3;45C103CA-FAFA-4BE8-96BB-786E15D2D8CA Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available 15;15;15;15;22;22;16;16;16;26 334;269;334;334;Not Available;Not Available;Not Available;Not Available;Not Available;761 92;87;92;92;365;395;365;365;365;395 Fluorouracil;Oxaliplatin;Leucovorin;Fluorouracil;Irinotecan HCL;bevacizumab;Fluorouracil;Fluorouracil;Leucovorin;BEVACIZUmab Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Clinical Progressive Disease 8;8;8;8;2;2;3;3;3;6 17;12;17;17;8;6;8;8;8;Not Available 800;170;210;2400;380;480;320;800;100;Not Available mg;mg;mg;mg;mg;mg;mg;mg;mg;Not Available PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable 1;1;1;1;2;2;2;2;2;Not Available IV;IV;IV;IV;IV;IV;IV;IV;IV;Not Available NO;NO;NO;NO;YES;YES;YES;YES;YES;NO Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Ancillary agent;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available 13600;1830;3570;35500;2800;2880;2368;5920;740;Not Available mg;mg;mg;mg;mg;mg;mg;mg;mg;Not Available Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;NO 2011;2011;2011;2011;2012;2012;2012;2012;2012;2013 NOT HISPANIC OR LATINO TCGA-DC-6156-F14256;TCGA-DC-6156-F21439;TCGA-DC-6156-F44747 8034c36c-4ea9-4b09-92aa-16a065c07755;88be6466-995e-49fe-ad62-19e57d048337;5A7F2351-C51B-4883-BF17-B89A17225F3F 26;13;26 Not Applicable;Not Applicable;Not Applicable 212;457;943 Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available;Progressive Disease Not Available;Not Available;NO 7;2;6 None;YES;NO None;NO;NO None;Not Available;Not Available None;30;30 None;Unknown;Unknown None;NO;NO None;Not Available;Not Available None;Not Available;Not Available NO;YES;YES WITH TUMOR;WITH TUMOR;WITH TUMOR YES;YES;YES Not Available;Not Available;Not Applicable NO;NO;NO Alive;Alive;Alive 2011;2012;2013 MALE 175 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES YES Not Available NO NO Not Available 22 YES Not Available 7 Not Available NO Not Available 1 Not Available 7 Not Available No 6156 YES Discrepancy Not Available 129.7 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IVA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M1a N2b T4a NO YES NO DC Rectum YES Alive 86.1 2011 2010 TCGA-AG-3999 853 Alive T3 N2 M0 Stage IIIC 1 791.0 Not Available Unknown 61 Rectum TCGA-AG-3999 60778da8-d99e-4e51-96a2-3e900b3978d9 NO Not Available 5 NO 18 -22311 Not Applicable 0 31 Not Available TCGA-AG-3999-D37659 4C69C48C-88A7-428F-85CB-0897E5F61623 Not Available 5 Not Available Not Available Not Available Clinical Progressive Disease 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available Not Available Chemotherapy Not Available Not Available Not Available NO 2012 Not Available TCGA-AG-3999-F38308 2288B663-B051-497A-BDE8-6E66274E268B 12 Not Applicable 853 Scheduled Follow-up Submission Progressive Disease NO 12 Unknown Unknown Not Available 791 Unknown NO Not Available Not Available YES TUMOR FREE YES Progressive Disease NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 32 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 20 Not Available No 3999 Not Available WITH TUMOR Not Available 9.67 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N2 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2008 TCGA-AG-3584 730 Dead T3 N2 M1 Stage IV 0 730 60 Rectum TCGA-AG-3584 b2c48624-a483-4b1d-9155-c0c80ed2f7a0 NO Not Available 2 Not Available 18 -22189 Not Applicable 0 0 Not Available TCGA-AG-3584-D37619;TCGA-AG-3584-D37620;TCGA-AG-3584-D37621;TCGA-AG-3584-D37622;TCGA-AG-3584-D37623;TCGA-AG-3584-D37624;TCGA-AG-3584-D37625;TCGA-AG-3584-D37626;TCGA-AG-3584-D37627 FB261DCE-FD6C-4A15-AA2E-ABE3012E6B22;079392F9-28CE-40D9-8097-908D753F5F41;1B4F9FA3-8976-4771-B187-EAFB66D56DB9;A2894A8C-69C0-42F7-8A2F-F63A9150C893;6B518DAA-0328-44A6-902E-ED9122718F0D;5C31B440-ED68-435C-89C1-337C2C1B9498;C91698E7-82FD-4FD9-B3C7-50E589A064F5;7F381F5C-41AD-4C61-974F-48B497AA77D4;B834783E-DAAC-45FF-9BDC-028EB4A7A879 n/a;n/a;n/a;n/a;n/a;n/a;n/a;n/a;n/a 5;5;5;5;5;5;5;5;5 274;274;274;396;396;396;580;580;580 92;92;92;335;335;335;427;427;427 Folinic acid;5-Fluorouracil;Irinotecan;Folinic acid;5-Fluorouracil;Oxaliplatin;Irinotecan;Irinotecan;Irinotecan Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease 12;12;12;12;12;12;12;12;12 Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO;NO;NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO;NO;NO;NO;NO;NO 2012;2012;2012;2012;2012;2012;2012;2012;2012 Not Available TCGA-AG-3584-F37960 7D8D99F8-7D40-4C9F-A65B-4F1E027C1B12 6 730 Not Available Scheduled Follow-up Submission Progressive Disease NO 12 NO WITH TUMOR YES Progressive Disease NO Dead 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 34 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 20 Not Available No 3584 Not Available WITH TUMOR Not Available 36.7 YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M1 N2 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2008 TCGA-DC-4749 762 Alive T2 N0 M0 Stage I 0 762 57 Rectosigmoid Junction TCGA-DC-4749 bf65c2cd-8348-488f-8485-9196ba42d17e NO Not Available Not Available NO 9 -21092 Not Applicable 0 335 Not Available NOT HISPANIC OR LATINO TCGA-DC-4749-F12834;TCGA-DC-4749-F33821 7c222c08-d934-40c0-ad3a-8b7b2ac286dc;807A6624-CDFD-46FE-AC61-39E0E91C7FF1 9;19 Not Applicable;Not Applicable 335;762 Not Available;Scheduled Follow-up Submission Not Available;Complete Remission/Response Not Available;NO 6;7 NO;NO TUMOR FREE;TUMOR FREE NO;NO Not Available;Complete Remission/Response NO;NO Alive;Alive 2011;2012 MALE 179 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 16 YES Not Available 6 Not Available NO Not Available 0 Not Available 0 Not Available No 4749 NO TUMOR FREE Not Available 1.3 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES DC Rectum YES Alive 87.1 2011 2010 TCGA-F5-6813 598 Dead T4a N2 M0 Stage IIIC 1 65.0 Not Available Unknown 70 Rectum TCGA-F5-6813 99d2c035-06a2-4bc3-8ff9-db875d232c93 NO Not Available Not Available NO 31 -25651 Not Applicable 0 21 Not Available NOT HISPANIC OR LATINO TCGA-F5-6813-F36421;TCGA-F5-6813-F41121 6C771380-606F-4064-8988-2086AF4558F7;27764851-F1F1-4249-90EA-60AECCB1FE9E 30;12 Not Applicable;598 252;Not Available Scheduled Follow-up Submission;Scheduled Follow-up Submission Unknown;Not Applicable NO;NO 10;3 NO;NO NO;NO Not Available;Not Available 65;65 Unknown;Unknown NO;NO Not Available;Not Available Not Available;Liver YES;YES WITH TUMOR;WITH TUMOR NO;NO Unknown;Unknown NO;NO Alive;Dead 2012;2013 MALE 174 Rectal Adenocarcinoma NO No C49.4 8140/3 C49.4 YES NO Not Available Not Available NO Not Available 12 NO Not Available 8 Not Available NO Not Available Not Available Not Available 12 0 No 6813 NO Not Available Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N2 T4a NO YES NO F5 Rectum NO Alive 85 2011 2011 TCGA-CL-5917 2376 Alive T3 N2 MX Stage IIIC 0 2376 71 Rectosigmoid Junction TCGA-CL-5917 7a285463-76f4-447d-bb04-336bb5ec1009 NO Not Available 30 YES Not Available -26084 Not Applicable 0 1826 Not Available NOT HISPANIC OR LATINO TCGA-CL-5917-F39667 7E32D4AF-107F-4EFE-AB08-7245987D9E05 29 Not Applicable 2376 Scheduled Follow-up Submission Complete Remission/Response NO 1 NO TUMOR FREE NO Complete Remission/Response NO Alive 2013 FEMALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available Not Available Not Available Not Available YES Not Available 6 Not Available NO Not Available Not Available Not Available Not Available Not Available No 5917 YES TUMOR FREE Not Available 0.6 Not Available Not Available WHITE Not Available RX Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable MX N2 T3 NO Not Available Not Available CL Rectum YES Alive Not Available 2011 2006 TCGA-AG-3578 974 Alive T3 N0 M0 Stage IIA 0 974 76 Rectum TCGA-AG-3578 04178a4f-14b0-45ba-aa3e-f21638e23765 NO Not Available Not Available Not Available 18 -27851 Not Applicable 0 0 Not Available Not Available TCGA-AG-3578-F37953 68DEE803-A0C8-48AE-A74A-C4AFE038FF25 6 Not Applicable 974 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE Not Available Rectal Mucinous Adenocarcinoma YES No C19 8480/3 C19.9 YES NO Not Available Not Available NO Not Available 25 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3578 Not Available WITH TUMOR Not Available 1.39 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AF-3912 0 Not Available Not Available TCGA-AF-3912 a4faf514-50af-43ed-b294-350ee0756250 Not Available Not Available Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available 3912 Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable Not Available Not Available Not Available Not Available Not Available Not Available AF Not Available Not Available Not Available Not Available Not Available Not Available TCGA-AG-3581 215 Alive T2 N0 M0 Stage I 0 215 63 Rectum TCGA-AG-3581 3124e819-292b-48e7-baac-8c5c4a86dc20 NO Not Available Not Available Not Available 18 -23345 Not Applicable 0 31 Not Available Not Available TCGA-AG-3581-F37957 A3B4E567-D491-41A7-ACAD-05643786269E 6 Not Applicable 215 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 33 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3581 Not Available WITH TUMOR Not Available .65 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AG-3731 1126 Alive T3 N1 M1 Stage IV 0 1126 65 Rectum TCGA-AG-3731 72756208-a5ed-47d2-8c4c-19a8d39f7b9d NO Not Available Not Available Not Available 18 -23923 Not Applicable 0 31 Not Available TCGA-AG-3731-D37642;TCGA-AG-3731-D37643;TCGA-AG-3731-D37644;TCGA-AG-3731-D37645 89CD8582-B07D-4C29-ABEB-E59268AC7FD7;0050963E-70D9-4754-BD4D-5CB6943EDB8A;D24F50D6-FB52-4277-8AB4-AC5123C639C7;ABCED613-88E1-44F3-8477-B6B2A8C63CF9 n/a;n/a;n/a;n/a 5;5;5;5 914;914;184;914 92;92;92;365 Folinic acid;5-Fluorouracil;Oxaliplatin;Irinotecan Partial Response;Partial Response;Partial Response;Partial Response 12;12;12;12 Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO 2012;2012;2012;2012 Not Available TCGA-AG-3731-F38010 C1F2C360-D785-4FC6-B913-948FEB5BD0C8 8 Not Applicable 1126 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response NO Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 34 Not Available Not Available 5 Not Available Not Available Not Available 0 Not Available 3 Not Available No 3731 Not Available WITH TUMOR Not Available 32.08 YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M1 N1 T3 NO NO YES AG Rectum Not Available Alive Not Available 2010 2004 TCGA-AF-A56L 2007 Alive T3 N2 M0 Stage IIIC 0 2007 48 Sigmoid Colon TCGA-AF-A56L C8FD1040-82A2-4CDA-AC49-C2F82B20CBAB Unknown Not Available Not Available NO 18 -17734 Not Applicable 0 1760 Not Available TCGA-AF-A56L-D42409;TCGA-AF-A56L-D42410;TCGA-AF-A56L-D42411;TCGA-AF-A56L-D42412 B297C576-C11B-4810-B6C6-C2859AF3D1DE;C6E884C2-2F25-4791-8E07-CF6A9034F43D;B413308D-C7F5-4902-8FF1-D44C8696D792;7CF68531-04CC-4FC7-B1CA-17DB824739E0 Not Available;Not Available;Not Available;Not Available 18;18;18;18 255;255;255;255 52;52;52;52 Oxaliplatin;Leucovorin;5FU;5FU Complete Response;Complete Response;Complete Response;Complete Response 4;4;4;4 Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO Chemotherapy;Ancillary;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO 2013;2013;2013;2013 Not Evaluated TCGA-AF-A56L-F51137 68BC9047-2C54-41C8-84B1-75CAD2DD4DA8 8 Not Applicable 2007 Scheduled Follow-up Submission Complete Remission/Response NO 11 NO TUMOR FREE YES Complete Remission/Response NO Alive 2013 FEMALE 159 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES Unknown Not Available Not Available YES MLH1-Expressed;MSH2-Expressed;PMS2-Expressed;MSH6-Expressed 23 YES NO 4 NO YES 0 0 5 10 Not Available No A56L Unknown TUMOR FREE YES 3.2 YES Complete Remission/Response BLACK OR AFRICAN AMERICAN NO RX Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N2 T3 NO NO YES AF Rectum NO Alive 74.3 2013 2008 TCGA-EI-6509 517 Alive T3 N2b M0 Stage IIIC 1 90.0 Liver Metastatic 53 Rectosigmoid Junction TCGA-EI-6509 652e503a-1be8-445b-96d6-ff114f911e76 NO Not Available 60 NO 13 -19666 Not Applicable 0 250 Not Available TCGA-EI-6509-D28629 04e8bf95-c20c-4276-a4ca-0acf83597ea1 Not Available 27 Not Available 395 FOLFOX Not Available 2 Not Available Not Available mg ADJUVANT Not Applicable Not Available IV YES Chemotherapy Not Available Not Available Not Available Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-6509-F28628 5912c28c-8a8c-470b-9957-574b055f17d6 27 Not Applicable 517 Scheduled Follow-up Submission Not Available Not Available 2 NO NO 127 90 Metastatic YES R0 Liver YES WITH TUMOR YES Not Available NO Alive 2012 MALE 178 Rectal Adenocarcinoma NO No C20 8263/3 C20.9 YES NO Not Available Not Available NO Not Available 10 YES Not Available 5 Not Available NO Not Available Not Available Not Available 7 0 No 6509 NO TUMOR FREE Not Available 2.8 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N2b T3 NO YES NO EI Rectum NO Alive 82 2011 2010 TCGA-AG-3609 608 Alive T3 N2 M0 Stage IIIC 0 608 65 Rectum TCGA-AG-3609 81dac02c-6e5f-4afe-9c90-12b5a4f26594 NO Not Available Not Available Not Available 18 -23925 Not Applicable 0 0 Not Available TCGA-AG-3609-D37631;TCGA-AG-3609-D37632;TCGA-AG-3609-D37633 DA3F2436-7363-4949-967D-5030F2F0C5D2;5E269C7F-6E92-4C6D-BC05-F089CC7FCA62;AE9AEFB7-BB2B-4B63-B031-2CAF2DB86DC3 Not Available;Not Available;Not Available 5;5;5 212;212;90 31;31;31 Folinic acid;5-Fluorouracil;Oxaliplatin Complete Response;Complete Response;Complete Response 12;12;12 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2012;2012;2012 Not Available TCGA-AG-3609-F38002 4079154D-89C9-43B5-8A09-C640D11057AB 8 Not Applicable 608 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 42 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 4 Not Available No 3609 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N2 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2008 TCGA-AG-4009 426 Alive T2 N0 M0 Stage I 0 426 83 Rectum TCGA-AG-4009 d63a90d4-730f-4916-af02-d06854221d7a NO Not Available Not Available Not Available 18 -30559 Not Applicable 0 30 Not Available Not Available TCGA-AG-4009-F38316 5C05C044-9629-4B5D-8E07-FFEB3F38E2C7 12 Not Applicable 426 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 16 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 4009 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum YES Alive Not Available 2010 2009 TCGA-EI-6506 625 Alive T3 N0 M0 Stage IIA 0 625 78 Rectosigmoid Junction TCGA-EI-6506 bcb21cdd-2f57-4df0-bbbe-a74fa5a654d6 NO Not Available 23 NO 9 -28587 Not Applicable 0 232 Not Available NOT HISPANIC OR LATINO TCGA-EI-6506-F28939 7f26f1a0-f9c3-4fbf-813d-e7667f4d9233 2 Not Applicable 625 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE 162 Rectal Adenocarcinoma NO No C20 8211/3 C20.9 YES NO Not Available Not Available Not Available Not Available 19 NO Not Available 6 Not Available NO Not Available 0 Not Available 0 Not Available No 6506 YES TUMOR FREE Not Available 2.8 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 Not Available YES NO EI Rectum NO Alive 65 2011 2010 TCGA-AG-3896 31 Alive T2 N0 M0 Stage I 0 31 85 Rectum TCGA-AG-3896 9af35239-ffb9-4d4f-889e-f743da271eef NO Not Available Not Available Not Available 18 -31046 Not Applicable 0 31 Not Available Not Available FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 12 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3896 Not Available WITH TUMOR Not Available Not Available Discrepancy Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum YES Alive Not Available 2010 2009 TCGA-AG-3882 608 Alive T2 N0 M0 Stage I 0 608 66 Rectum TCGA-AG-3882 92c65e5a-3f07-49d9-ab69-46a0eb86ae88 NO Not Available Not Available Not Available 18 -24198 Not Applicable 0 0 Not Available Not Available TCGA-AG-3882-F38013 6403B608-FB0D-4B72-A758-FD8225E97E8E 8 Not Applicable 608 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C18.9 8140/3 C18.9 YES NO Not Available Not Available NO Not Available 18 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3882 Not Available WITH TUMOR Not Available .33 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum YES Alive Not Available 2010 2008 TCGA-AG-A02G 1185 Dead T2 N1 M1 Stage IV 1 578.0 Not Available Unknown 66 Rectum TCGA-AG-A02G 17878cb0-a8f9-43a4-911c-0f94c2a5e3df NO Not Available Not Available Not Available 15 -24259 Not Applicable 0 0 Not Available TCGA-AG-A02G-D37682;TCGA-AG-A02G-D37683;TCGA-AG-A02G-D37684;TCGA-AG-A02G-D37685;TCGA-AG-A02G-D37686 7458F01A-6F47-42AC-AB9F-525BFC8D3A2F;A6893A84-4202-474B-9A3D-78E7E865113C;A8310B34-29AD-410D-A5DE-FCDD7CBE7AEE;E6F1FA31-3AF9-45D0-A70B-38EF81B6A288;2DCEA1E6-7D2F-46E0-9D15-4069C8FFC067 n/a;n/a;n/a;n/a;n/a 5;5;5;5;5 1096;1096;242;242;1096 28;28;28;28;851 Folinic acid;5-Fluorouracil;Irinotecan;Bevacizumab;Oxaliplatin Partial Response;Partial Response;Partial Response;Partial Response;Partial Response 12;12;12;12;12 Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available YES;NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO;NO 2012;2012;2012;2012;2012 Not Available TCGA-AG-A02G-F38515 76E8C5E1-6AC3-4633-91B8-5DE5EA85A1A2 16 1185 Not Available Scheduled Follow-up Submission Partial Remission/Response NO 12 Unknown Unknown Not Available 578 Unknown NO Not Available Not Available YES WITH TUMOR YES Partial Remission/Response NO Dead 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 16 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 3 Not Available No A02G Not Available WITH TUMOR Not Available 2.32 YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M1 N1 T2 NO NO YES AG Rectum YES Alive Not Available 2011 2007 TCGA-EI-6883 350 Alive T3 N0 M0 Stage IIC 0 350 63 Rectosigmoid Junction TCGA-EI-6883 468c2ecb-a21f-49a7-91f3-63d3ef266cf8 NO Not Available 21 NO 18 -23268 Not Applicable 0 121 Not Available TCGA-EI-6883-D29852 f1e06e96-ffc3-4cf9-962b-2e718c64a40e Not Available 30 111 55 5fluorouracil+leucovorin Not Available 3 3 Not Available mg/m2 ADJUVANT Not Applicable Not Available IV NO Chemotherapy Not Available Not Available mg Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-6883-F29851 121ec34e-c483-471e-9971-3c0f8c1c5642 30 Not Applicable 350 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE YES Not Available NO Alive 2012 MALE 180 Rectal Adenocarcinoma NO No C20 8211/3 C20.9 YES NO Not Available Not Available NO Not Available 16 NO NO 7 Not Available NO Not Available 0 Not Available 0 Not Available No 6883 NO TUMOR FREE Not Available 1.6 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIC Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO EI Rectum NO Alive 73 2011 2011 TCGA-DY-A0XA 3846 Alive T3 N0 M0 Stage IIA 0 3846 57 Rectosigmoid Junction TCGA-DY-A0XA 9df9af6b-00b0-47af-aac7-b52dac399ba5 YES Normal Not Available Not Available 21 -21115 Not Applicable 0 3635 3635 TCGA-DY-A0XA-D30448 3A895248-930E-46DE-99A6-2D6B7732C640 Not Available 10 239 47 Mayo 425-20 Complete Response 4 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 NOT HISPANIC OR LATINO TCGA-DY-A0XA-F17214 3CD987E9-DD78-41B5-950C-F0AA56C3F6D2 25 Not Applicable 3846 Scheduled Follow-up Submission Not Available Not Available 10 NO Not Available Not Available Not Available Not Available Alive 2011 FEMALE 159 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES YES Not Available NO Not Available Not Available 14 NO NO 6 Not Available Not Available 0 0 6 0 Not Available No A0XA Not Available Not Available Not Available Not Available YES Not Available WHITE Not Available Primary Tumor Field TCGA-DY-A0XA-R30542 229799B2-D7A6-4815-B8AF-6CD0244C1015 Not Available 12 142 104 Not Available 4 Not Available 4900 NO Not Available Not Applicable ADJUVANT Not Available Not Available 2012 Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES DY Rectum NO Alive 64 2011 2001 TCGA-AH-6547 76 Dead T3 N0 MX 0 76 79 Rectosigmoid Junction TCGA-AH-6547 c7162d11-4bdc-41cd-a964-46fc416829db NO Not Available 22 YES 4 -29030 Not Applicable 0 44 Not Available Not Available TCGA-AH-6547-F42779 1B86C4DB-B760-410E-8DE8-AD7E62873CC9 30 76 Not Available Scheduled Follow-up Submission Complete Remission/Response NO 4 NO TUMOR FREE NO Complete Remission/Response NO Dead 2013 FEMALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 21 NO Not Available 8 Not Available Not Available Not Available 0 Not Available 0 Not Available No 6547 Not Available TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable MX N0 T3 Not Available NO YES AH Rectum NO Alive Not Available 2011 2010 TCGA-AG-3887 1124 Alive T3 N0 M0 Stage IIA 1 1064.0 Not Available Unknown 68 Rectum TCGA-AG-3887 8c7ccdb0-7653-4a8d-86b6-de39afc40765 NO Not Available Not Available Not Available 18 -24960 Not Applicable 0 28 Not Available TCGA-AG-3887-D37650;TCGA-AG-3887-D37651;TCGA-AG-3887-D37652 B21661DA-72BC-41E0-8FB1-7FD3C9904564;D19E88BF-FD23-407D-8687-8DBC9EF02F86;8EDBD3BB-086B-4166-A971-A245C564BF9C Not Available;Not Available;Not Available 5;5;5 Not Available;Not Available;Not Available 1095;1095;1095 Irinotecan;Capecitabine;Bevacizumab Not Applicable;Not Applicable;Not Applicable 12;12;12 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available YES;YES;Not Available Chemotherapy;Chemotherapy;Targeted Molecular therapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2012;2012;2012 Not Available TCGA-AG-3887-F38015 E26D0933-7503-4204-A9BC-D2C98C23E183 8 Not Applicable 1124 Scheduled Follow-up Submission Progressive Disease NO 12 Unknown Unknown Not Available 1064 Unknown NO Not Available Not Available YES WITH TUMOR YES Not Applicable YES Alive 2012 MALE Not Available Rectal Mucinous Adenocarcinoma YES No C20 8480/3 C20.9 YES NO Not Available Not Available NO Not Available 14 YES Not Available 5 Not Available Not Available Not Available 1 Not Available 0 Not Available No 3887 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available Distant Recurrence TCGA-AG-3887-R38359 881BDAC4-E4FA-4343-8D79-D38218E4C13F Not Available 13 Not Available 1095 Not Applicable 12 Not Available Not Available YES External Not Applicable Not Available Not Available Not Available 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2009 TCGA-F5-6464 303 Dead T4b N2a M0 Stage IIIC 0 303 77 Rectum TCGA-F5-6464 8b4383b1-a684-41ea-bfb0-c84e6f5b287d NO Not Available Not Available NO 20 -28168 Not Applicable 0 0 Not Available NOT HISPANIC OR LATINO TCGA-F5-6464-F29829 3E1AF942-0943-4749-A350-BDEB23F68EAE 29 303 Not Available Scheduled Follow-up Submission Not Available Not Available 3 NO Not Available NO Not Available NO Dead 2012 FEMALE 159 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 4 NO Not Available 6 Not Available NO Not Available Not Available Not Available 4 0 No 6464 NO Not Available Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N2a T4b NO YES NO F5 Rectum NO Alive 68 2011 2011 TCGA-AG-4021 121 Dead T3 N2 M1 Stage IV 1 0.0 Not Available Unknown 84 Rectum TCGA-AG-4021 6dafce6c-b2a9-4b23-b9f8-b71e01616389 YES Not Available Not Available Not Available 18 -31015 Not Applicable 0 0 Not Available Not Available TCGA-AG-4021-F38318 3B59F395-585D-48A1-9E25-96B50C5B8380 12 121 Not Available Scheduled Follow-up Submission Progressive Disease NO 12 Unknown Unknown Not Available 0 Unknown NO Not Available Not Available YES WITH TUMOR NO Not Available NO Dead 2012 FEMALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 17 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 5 Not Available No 4021 Not Available WITH TUMOR Not Available 3101 YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M1 N2 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2005 TCGA-AG-A026 59 Dead T4 N0 M0 Stage II 0 59 66 Rectum TCGA-AG-A026 31bd8589-378c-40e5-8b7f-3b4c81f304be NO Not Available Not Available Not Available 15 -24413 59 0 Not Available Not Available Not Available MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 15 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available No A026 Not Available WITH TUMOR Not Available 9.65 YES Not Available Not Available Not Available R1 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage II Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T4 NO NO YES AG Rectum YES Dead Not Available 2011 2006 TCGA-AG-4001 1096 Alive T3 N0 M0 Stage IIA 0 1096 74 Rectum TCGA-AG-4001 d846228f-67af-4b3b-9796-dbc263c2054c NO Not Available Not Available Not Available 18 -27302 Not Applicable 0 31 Not Available Not Available TCGA-AG-4001-F38309 8E956586-D2C3-4499-80E4-62A975087484 12 Not Applicable 1096 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 29 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 4001 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2009 TCGA-F5-6863 361 Dead T4a N1 M0 Stage IIIB 1 191.0 Not Available Unknown 71 Rectum TCGA-F5-6863 72e640f2-869f-4aef-8ebe-b127f3e7048a NO Not Available Not Available NO 7 -25936 Not Applicable 0 23 Not Available TCGA-F5-6863-D35412;TCGA-F5-6863-D35413;TCGA-F5-6863-D35414;TCGA-F5-6863-D35415 52352390-D906-4CD9-A1EF-85A68856259C;C49E0FEE-4847-4946-83B7-457EE6C96D86;A8C20AB5-CB1C-4F37-B128-2926781CD0FF;DDBA0B34-8873-49AE-865D-C33764098442 Not Available;Not Available;Not Available;Not Available 26;26;26;26 251;251;251;289 196;196;196;261 Etoposide;Leucovorin;5-Fluorouracil;Xeloda Stable Disease;Stable Disease;Stable Disease;Clinical Progressive Disease 9;9;9;9 Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO 2012;2012;2012;2012 NOT HISPANIC OR LATINO TCGA-F5-6863-F35411 833EDE3F-7468-4A8B-9A54-4618AAA31C3C 26 361 Not Available Scheduled Follow-up Submission Progressive Disease NO 9 YES NO Not Available 191 Unknown NO Not Available Not Available YES WITH TUMOR NO Unknown NO Dead 2012 FEMALE 166 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 6 NO Not Available 10 Not Available NO Discrepancy Not Available Discrepancy 3 0 No 6863 NO Not Available Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1 T4a NO YES NO F5 Rectum NO Alive 77 2011 2011 TCGA-AF-3913 316 Dead T3 N1 M1 Stage IV 0 316 60 Rectosigmoid Junction TCGA-AF-3913 03a9dd9d-62ae-4acd-9272-389274858f3d NO Not Available Not Available YES 8 -21970 316 0 Not Available Not Available TCGA-AF-3913-D15342;TCGA-AF-3913-D15339 37cd71bc-2e4e-467d-8695-ebb6dae9c2e0;55dec849-87fa-4e9d-b34a-25d3f86fd865 Not Available;Not Available 19;19 313;313 231;231 Xeloda;Oxaliplatin Not Available;Not Available 9;9 3;3 Not Available;Not Available Not Available;Not Available PALLIATIVE;PALLIATIVE Not Applicable;Not Applicable 1;1 PO;IV NO;NO Chemotherapy;Chemotherapy Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available 2011;2011 NOT HISPANIC OR LATINO TCGA-AF-3913-F4474 b71024aa-c00c-4044-b065-106e1a7e4755 7 316 Not Available Not Available Not Available Not Available 12 NO WITH TUMOR YES Not Available NO Dead 2010 MALE 180 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES YES Not Available NO NO Not Available 26 YES Not Available 11 Not Available NO Not Available Not Available Not Available 1 Not Available Yes 3913 Not Available WITH TUMOR Not Available 41.5 YES Not Available BLACK OR AFRICAN AMERICAN Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M1 N1 T3 YES YES NO AF Rectum NO Dead 95.5 2010 2009 TCGA-EI-7004 257 Alive T4a N2b M0 0 257 37 Rectosigmoid Junction TCGA-EI-7004 b2db7f47-540f-4bd3-81bb-d686b0225201 NO Not Available 30 NO 18 -13566 Not Applicable 0 62 Not Available TCGA-EI-7004-D29858 f1a23525-1b5a-4f36-93f3-2c78da97de62 Not Available 30 188 41 xeloda Not Available 3 7 Not Available mg/m2 ADJUVANT Not Applicable Not Available IV NO Chemotherapy Not Available Not Available mg Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-7004-F29857 24449210-a8d9-453a-a9e6-4b9a490f414f 30 Not Applicable 257 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE YES Not Available NO Alive 2012 FEMALE 172 Rectal Mucinous Adenocarcinoma NO No C19 8480/3 C19.9 YES NO Not Available Not Available NO Not Available 30 YES NO 7 Not Available NO Not Available 0 Not Available 30 Not Available No 7004 NO TUMOR FREE Not Available 3.2 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Discrepancy Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N2b T4a Not Available YES NO EI Rectum NO Alive 88 2011 2011 TCGA-DC-6160 1339 Alive T2 N0 M0 Stage I 0 1339 68 Rectosigmoid Junction TCGA-DC-6160 2bd23664-453b-4fbf-823e-6dbcde0c4a2a NO Not Available 12 YES 26 -24990 Not Applicable 0 608 Not Available NOT HISPANIC OR LATINO TCGA-DC-6160-F14254;TCGA-DC-6160-F21436;TCGA-DC-6160-F44764 1d0ea0de-0ee7-4ce1-985a-8ad6279a8170;5acec62e-e1c9-4f91-9be0-ac514b405632;5E71EE91-8CD4-40F6-BE71-22B8F49322BA 26;13;26 Not Applicable;Not Applicable;Not Applicable 608;914;1339 Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available;Not Applicable Not Available;Not Available;NO 7;2;6 NO;NO;NO TUMOR FREE;TUMOR FREE;TUMOR FREE NO;NO;NO Not Available;Not Available;Not Applicable NO;NO;NO Alive;Alive;Alive 2011;2012;2013 MALE 175.4 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 8 NO Not Available 7 Not Available NO Not Available 0 Not Available 0 Not Available No 6160 YES TUMOR FREE Not Available 5.2 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES DC Rectum YES Alive 100.1 2011 2009 TCGA-EF-5831 127 Alive T3 N0 M0 Stage IIA 0 127 72 Rectum TCGA-EF-5831 4d5437b3-b6a0-4d17-a7aa-4f2b790e4532 NO Not Available Not Available Not Available 15 -26331 Not Applicable 0 73 Not Available NOT HISPANIC OR LATINO TCGA-EF-5831-F69009 10064861-41E4-4F83-90AE-ABE08AF5958B 24 Not Applicable 127 Scheduled Follow-up Submission Not Applicable YES 12 NO Not Available NO Not Applicable NO Alive 2014 MALE 162 Rectal Adenocarcinoma Not Available No C20 8140/3 C20.9 YES NO Not Available Not Available Not Available Not Available Not Available Not Available Not Available 7 Not Available Not Available Not Available Not Available Not Available Not Available Not Available No 5831 Not Available TUMOR FREE Not Available Not Available NO Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES EF Rectum Not Available Alive 60 2011 2010 TCGA-AG-A025 1520 Alive T1 N0 M0 Stage I 0 1520 62 Rectum TCGA-AG-A025 9d7e0672-0a9e-4dbf-a583-80f4eb086ec6 NO Not Available Not Available Not Available 15 -22952 Not Applicable 0 1520 Not Available Not Available FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 11 Not Available Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available No A025 Not Available WITH TUMOR Not Available 0.75 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T1 NO NO YES AG Rectum Not Available Alive Not Available 2011 2006 TCGA-AH-6549 532 Alive T3 NX MX 0 532 66 Rectum TCGA-AH-6549 107cb92b-6231-4e7a-af05-1f5de5981947 Not Available Not Available 10 YES 21 -24337 Not Applicable 0 6 Not Available Not Available TCGA-AH-6549-F43206 5BB1A23A-31FC-4468-B638-937E583E37E9 15 Not Applicable 532 Scheduled Follow-up Submission Complete Remission/Response NO 5 NO TUMOR FREE NO Complete Remission/Response NO Alive 2013 MALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available 7 Not Available Not Available Not Available 0 Not Available Not Available Not Available No 6549 Not Available Not Available Not Available 1.8 NO Not Available WHITE Not Available RX Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable MX NX T3 Not Available NO YES AH Rectum Not Available Alive Not Available 2011 2010 TCGA-DC-6683 762 Alive T3 N1b M0 Stage IIIB 0 762 43 Rectosigmoid Junction TCGA-DC-6683 16a9e1c5-85c2-4930-a16c-af59114bac9a NO Not Available 70 NO Not Available -15918 Not Applicable 0 153 Not Available TCGA-DC-6683-D16997;TCGA-DC-6683-D16998;TCGA-DC-6683-D16996;TCGA-DC-6683-D17000 7b26e472-0f10-4ca1-9bb1-4dbd2a4852e9;102d8593-ffff-4a1e-8f0d-0d8e1dac97af;c35d6f62-4fe4-460c-9ca1-eef4461e775d;d212da89-e3a1-4588-ab55-5f0513443f06 Not Available;Not Available;Not Available;Not Available 18;18;18;18 214;214;214;214 50;50;50;50 Fluorouracil;Oxaliplatin;Fluorouracil;Leucovorin Calcium Not Available;Not Available;Not Available;Not Available 4;4;4;4 12;12;12;12 2400;170;800;800 mg;mg;mg;mg ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable;Not Applicable 1;1;1;1 IV;IV;IV;IV NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes Not Available;Not Available;Not Available;Ancillary 28800;1980;9600;9600 mg;mg;mg;mg Not Available;Not Available;Not Available;Not Available 2012;2012;2012;2012 NOT HISPANIC OR LATINO TCGA-DC-6683-F15652;TCGA-DC-6683-F30877;TCGA-DC-6683-F44770 129f3071-ccf1-429c-a6f9-fb410ce1cd32;7389f972-ac7f-48a5-9216-3e559772ec96;612F090F-CF93-4239-B18D-1FDE3FD329D8 Not Available;18;26 Not Applicable;Not Applicable;Not Applicable 153;306;762 Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available;Not Applicable Not Available;Not Available;NO 8;4;6 NO;NO;NO TUMOR FREE;TUMOR FREE;TUMOR FREE YES;YES;YES Not Available;Not Available;Not Applicable NO;NO;NO Alive;Alive;Alive 2011;2012;2013 MALE 183 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available YES MLH1-Not Expressed;MSH2-Not Expressed;PMS2-Not Expressed;MSH6-Not Expressed 27 NO Not Available 8 Not Available NO Not Available 0 Not Available 3 Not Available No 6683 YES TUMOR FREE Not Available 11.1 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1b T3 NO YES NO DC Rectum YES Alive 82.6 2011 2011 TCGA-EI-6512 538 Alive T3 N1 M0 Stage IIIB 0 538 64 Rectosigmoid Junction TCGA-EI-6512 25b43e40-e1f9-42a0-8052-5138f381eed9 NO Not Available Not Available NO 13 -23537 Not Applicable 0 20 Not Available TCGA-EI-6512-D28635 b21dc457-7653-4411-931f-6d024c1c33c1 Not Available 27 Not Available 20 FOLFOX Not Available 2 Not Available Not Available mg ADJUVANT Not Applicable Not Available IV YES Chemotherapy Not Available Not Available Not Available Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-6512-F28634 803086c2-dd12-4f44-a330-d862b01edd4c 30 Not Applicable 538 Scheduled Follow-up Submission Not Available Not Available 1 NO TUMOR FREE YES Not Available NO Alive 2012 FEMALE 170 Rectal Adenocarcinoma NO No C20 8263/3 C20.9 YES NO Not Available Not Available NO Not Available 17 NO Not Available 5 Not Available NO Not Available 0 Not Available 1 00 No 6512 NO TUMOR FREE Not Available 1.0 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO YES NO EI Rectum NO Alive 61 2011 2010 TCGA-DC-6155 425 Alive T2 N1b M0 Stage IIIA 0 425 31 Rectosigmoid Junction TCGA-DC-6155 eb75ca70-e60f-453f-820c-485390abad88 NO Not Available 15 NO 26 -11381 Not Applicable 0 225 Not Available TCGA-DC-6155-D15164;TCGA-DC-6155-D15163;TCGA-DC-6155-D15168;TCGA-DC-6155-D15166 0b815912-6451-40de-8bdf-676366ba19f1;c6d39c6c-9b36-4771-9d2b-f7fd8791e5f4;2280d088-6312-4936-90a6-1076aecf0b11;f7f4fe18-913d-4ce0-82a3-d4dc4d4b8759 Not Available;Not Available;Not Available;Not Available 12;12;12;12 239;71;239;239 57;57;57;57 Leucovorin;Oxaliplatin;Fluorouracil;Fluorouracil Not Available;Not Available;Not Available;Not Available 8;8;8;8 11;2;12;12 160-650;130;1900;650-600 mg;mg;mg;mg ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable;Not Applicable 1;1;1;1 IV;IV;IV;IV NO;NO;NO;NO Other, specify in notes;Chemotherapy;Chemotherapy;Chemotherapy Ancillary agent;Not Available;Not Available;Not Available 5970;260;22800;7600 mg;mg;mg;mg Not Available;Not Available;Not Available;Not Available 2011;2011;2011;2011 NOT HISPANIC OR LATINO TCGA-DC-6155-F14246;TCGA-DC-6155-F21438 0f656363-f199-4bec-961d-8749f3342458;0782a1e8-9553-4100-bf08-26a519b83272 26;13 Not Applicable;Not Applicable 225;425 Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available Not Available;Not Available 7;2 NO;NO TUMOR FREE;TUMOR FREE YES;YES Not Available;Not Available NO;NO Alive;Alive 2011;2012 FEMALE 163 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available YES Not Available 31 NO Not Available 7 Not Available NO Not Available 1 Not Available 3 Not Available No 6155 NO TUMOR FREE Not Available 1.3 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1b T2 NO YES NO DC Rectum YES Alive 55.3 2011 2010 TCGA-AG-A00Y 700 Alive T3 N0 M0 Stage IIA 1 123.0 Not Available Unknown 68 Rectum TCGA-AG-A00Y c7e09161-60d6-4dff-a840-7cec3bb7a30a NO Not Available Not Available Not Available 15 -24837 Not Applicable 0 0 Not Available Not Available TCGA-AG-A00Y-F38317 9AB30C5D-E8CA-452C-B427-B88A9C1BF474 12 Not Applicable 700 Scheduled Follow-up Submission Complete Remission/Response NO 12 Unknown Unknown Not Available 123 Unknown NO Not Available Not Available YES TUMOR FREE NO Complete Remission/Response NO Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 31 NO Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available No A00Y Not Available WITH TUMOR Not Available 4.21 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 YES NO YES AG Rectum NO Alive Not Available 2011 2008 TCGA-AG-3725 0 Alive T3 N2 M0 Stage III 0 0 90 Rectum TCGA-AG-3725 fd798ddf-7273-49b8-b13c-d9909c8c87ff NO Not Available Not Available Not Available 18 -32872 Not Applicable 0 0 Not Available Not Available TCGA-AG-3725-F38008 2217DE25-DDB6-4010-ACF8-2A1D42F8449C 8 Not Applicable 0 Scheduled Follow-up Submission Partial Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 18 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 5 Not Available No 3725 Not Available WITH TUMOR Not Available 6.08 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage III Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N2 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2005 TCGA-AG-3890 518 Alive T2 N0 M0 Stage I 0 518 62 Rectum TCGA-AG-3890 e2d395f8-bf13-4fe4-8031-683b0eedd875 NO Not Available Not Available Not Available 18 -22950 Not Applicable 0 0 Not Available Not Available TCGA-AG-3890-F38016 5D2BAB20-E659-4551-BAA2-CA11D0084633 8 Not Applicable 518 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 12 YES Not Available 5 Not Available Not Available Not Available 1 Not Available 0 Not Available Yes 3890 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum YES Alive Not Available 2010 2009 TCGA-AG-4008 518 Alive T3 N0 M0 Stage IIA 0 518 63 Rectum TCGA-AG-4008 72802851-9340-4c5f-a90b-23b7afd7577a NO Not Available Not Available Not Available 18 -23192 Not Applicable 0 31 Not Available TCGA-AG-4008-D37663;TCGA-AG-4008-D37664 5DD8AC7E-EEB1-4222-99A5-6B18A6A0B3CD;E2E9F3AE-4CA2-4A37-B87C-AD62DCF39099 n/a;n/a 5;5 92;92 61;61 5-Fluorouracil;Folinic acid Complete Response;Complete Response 12;12 Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Applicable;Not Applicable Not Available;Not Available Not Available;Not Available NO;NO Chemotherapy;Chemotherapy Not Available;Not Available Not Available;Not Available Not Available;Not Available NO;NO 2012;2012 Not Available TCGA-AG-4008-F38314 8D76876D-3055-4BCB-B936-84AD2692A892 12 Not Applicable 518 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response NO Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C18.9 8140/3 C18.9 YES NO Not Available Not Available NO Not Available 15 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available Yes 4008 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2008 TCGA-BM-6198 646 Alive T3 N1 Stage IIIB 0 646 73 Rectum TCGA-BM-6198 a46be4e1-260c-4ce9-8b0f-1326d90c697f NO Not Available Not Available NO 14 -26837 Not Applicable 0 310 Not Available TCGA-BM-6198-D13221 50c06958-f062-4dd4-8af3-2e20727551da Not Available 21 261 78 Xeloda Not Available 6 Not Available Not Available Not Available ADJUVANT Not Applicable 1 PO NO Chemotherapy Not Available Not Available Not Available Not Available 2011 NOT HISPANIC OR LATINO TCGA-BM-6198-F13216;TCGA-BM-6198-F34043 a02c3a99-0e40-4502-9e84-7146dbd94644;125975C5-0D45-4255-8A2B-D2B4A609AA24 21;26 Not Applicable;Not Applicable 310;646 Not Available;Scheduled Follow-up Submission Not Available;Complete Remission/Response Not Available;NO 6;7 NO;NO TUMOR FREE;TUMOR FREE YES;NO Not Available;Complete Remission/Response YES;NO Alive;Alive 2011;2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 11 NO Not Available 4 Not Available NO Not Available 0 Not Available 0 Not Available Yes 6198 NO Not Available Not Available 81.3 YES Not Available WHITE Not Available Primary Tumor Field TCGA-BM-6198-R13217 4e30045a-d2c1-4b50-9a10-295cb58133bd 1 21 174 139 Not Available 6 23 4140 NO EXTERNAL BEAM Not Applicable ADJUVANT Not Available cGy 2011 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable Not Available N1 T3 NO YES NO BM Rectum NO Alive 119 2011 2010 TCGA-AG-3611 424 Alive T3 N0 M0 Stage IIA 0 424 72 Rectum TCGA-AG-3611 fb632146-92c7-40d9-acc3-6dc4a2d499be NO Not Available Not Available Not Available 18 -26420 Not Applicable 0 0 31 TCGA-AG-3611-D37634;TCGA-AG-3611-D37635 40EA7062-DFF9-4BC9-9EBA-7AF603EFA401;0D72C3B9-12DB-45F9-8E9B-575140447392 n/a;n/a 5;5 973;973 850;850 Folinic acid;5-Fluorouracil Complete Response;Complete Response 12;12 Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Applicable;Not Applicable Not Available;Not Available Not Available;Not Available NO;NO Chemotherapy;Chemotherapy Not Available;Not Available Not Available;Not Available Not Available;Not Available NO;NO 2012;2012 Not Available TCGA-AG-3611-F38004 24C1EEB8-9025-45F0-B7DC-61DC856F24A6 8 Not Applicable 424 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response NO Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 19 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available Yes 3611 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2009 TCGA-AG-3593 1035 Alive T3 N0 M0 Stage IIA 0 1035 72 Rectum TCGA-AG-3593 10290e91-9784-4f94-8daa-b5d9a8b0efb9 NO Not Available 2 Not Available 18 -26480 Not Applicable 0 0 Not Available TCGA-AG-3593-D37629 F0328A7A-9B62-404F-AC16-CA9495F2E404 Not Available 5 92 61 5-Fluorouracil Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 Not Available TCGA-AG-3593-F37965 4E44995A-B8E7-4642-93AF-4B02C6E1876E 6 Not Applicable 1035 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response YES Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 38 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3593 Not Available WITH TUMOR Not Available 9.76 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-3593-R38353 70576A03-AF1B-4F84-B629-6F9D88A70FAC Not Available 13 92 61 Complete Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AG-A00C 183 Alive T3 N1 M0 Stage IIIB 0 183 49 Rectum TCGA-AG-A00C ff004403-8cc5-43e6-bd1c-dde4eb1e6193 NO Not Available 6 Not Available 15 -18201 Not Applicable 0 0 Not Available TCGA-AG-A00C-D37666;TCGA-AG-A00C-D37667;TCGA-AG-A00C-D37668 0480C952-95AB-4119-B285-88C9B48B46CF;AB4C44C6-717B-46CA-8881-BCDB2B3C9D28;66F94F54-0A6F-4BA1-8050-01A385AB66F3 Not Available;Not Available;Not Available 5;5;5 213;213;213 92;61;92 Folinic acid;5-Fluorouracil;Oxaliplatin Complete Response;Complete Response;Complete Response 12;12;12 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2012;2012;2012 Not Available TCGA-AG-A00C-F38313 B2E6175A-488F-4340-8048-4EF3DC25477D 12 Not Applicable 183 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response YES Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 24 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 1 Not Available No A00C Not Available WITH TUMOR Not Available 4.31 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-A00C-R38312 ACD5E3F1-5863-4451-B18E-A113DE5709D1 Not Available 13 92 61 Complete Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES AG Rectum NO Alive Not Available 2011 2007 TCGA-AG-A01W 0 Alive T3 N0 M0 Stage II 0 0 67 Rectum TCGA-AG-A01W 74543fa4-ce73-46e4-9c59-224e8242b4a2 NO Not Available Not Available Not Available 15 -24745 Not Applicable 0 0 Not Available TCGA-AG-A01W-D37677 E11038FD-3C7C-46DA-A03B-2AB5352DCDD5 n/a 5 184 62 5-Fluorouracil Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 Not Available FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 20 YES Not Available 6 Not Available Not Available Not Available 2 Not Available 0 Not Available No A01W Not Available WITH TUMOR Not Available 2.07 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-A01W-R38370 E84AABE3-40C3-4825-B4B7-7DAE74BD1409 Not Available 13 92 31 Complete Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage II Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum YES Alive Not Available 2011 2004 TCGA-DC-6157 1581 Alive T2 N0 M0 Stage I 0 1581 48 Rectosigmoid Junction TCGA-DC-6157 634d542b-a72f-408b-9fef-65ef6c45f882 NO Not Available 3 NO 26 -17807 Not Applicable 0 850 Not Available NOT HISPANIC OR LATINO TCGA-DC-6157-F14258;TCGA-DC-6157-F21435;TCGA-DC-6157-F44763 359a768b-2515-4207-93cf-ddcf6785d26d;ea0ef720-c662-4555-bf4c-bf07955cab84;AC62B632-9414-49DC-9008-D51B00393253 26;13;26 Not Applicable;Not Applicable;Not Applicable 850;1095;1581 Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available;Not Applicable Not Available;Not Available;NO 7;2;6 NO;NO;NO TUMOR FREE;TUMOR FREE;TUMOR FREE NO;NO;NO Not Available;Not Available;Not Applicable NO;NO;NO Alive;Alive;Alive 2011;2012;2013 MALE 185 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 21 NO Not Available 7 Not Available NO Not Available 1 Not Available 0 Not Available No 6157 NO TUMOR FREE Not Available 2.2 YES Not Available BLACK OR AFRICAN AMERICAN Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES DC Rectum NO Alive 116 2011 2009 TCGA-AG-3599 366 Alive T2 N0 M0 Stage I 0 366 70 Rectum TCGA-AG-3599 2a7903cc-345d-48f7-9fec-b4a5f09f8002 NO Not Available Not Available Not Available 18 -25749 Not Applicable 0 30 Not Available Not Available TCGA-AG-3599-F37992 6576F8BC-A53A-45B0-A285-E2C6B99040F4 8 Not Applicable 366 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 MALE Not Available Not Available NO No C19 8480/3 C19.9 YES NO Not Available Not Available NO Not Available 12 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3599 Not Available WITH TUMOR Not Available 3.36 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-CI-6619 184 Alive T3 N1c M1 Stage IV 0 184 41 Rectum TCGA-CI-6619 3b55aa84-9fdc-4125-8d39-d8949de2a1b3 Not Available Not Available Not Available Not Available 15 -15322 Not Applicable 0 184 Not Available NOT HISPANIC OR LATINO TCGA-CI-6619-F69600 9D955ED0-3230-4E13-A370-2F4C06B5B2D9 14 Not Applicable Not Available Scheduled Follow-up Submission Unknown YES 1 Unknown Not Available Not Available Not Available Not Available Not Available 2015 MALE Not Available Rectal Adenocarcinoma Not Available No C20 8140/3 C20.9 YES Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available 9 Not Available Not Available Not Available Not Available Not Available Not Available Not Available No 6619 Not Available Not Available Not Available 52.7 Not Available Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M1 N1c T3 Not Available NO YES CI Rectum Not Available Alive Not Available 2011 2010 TCGA-DY-A1DG 1566 Dead T3 N1 M1 Stage IVA 1 592.0 Not Available Unknown 75 Rectum TCGA-DY-A1DG 89e4905e-31bb-4125-9262-93f600aed7e5 YES Normal Not Available YES Not Available -27396 1566 0 Not Available Not Available NOT HISPANIC OR LATINO TCGA-DY-A1DG-F19044 FF271A21-AF76-4913-9379-E64D89FC2DE0 2 1566 Not Available Scheduled Follow-up Submission Not Available Not Available 12 Not Available Not Available Not Available 592 Unknown NO Not Available Not Available YES Not Available Not Available Not Available Not Available Dead 2011 MALE 175 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES YES Not Available NO Not Available Not Available 8 Not Available NO 5 Not Available Not Available 0 0 5 2 Not Available No A1DG Not Available Not Available Not Available Not Available YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IVA Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M1 N1 T3 NO NO YES DY Rectum Not Available Dead 86 2011 2000 TCGA-AG-3592 1035 Alive T3 N0 M0 Stage IIA 0 1035 68 Rectum TCGA-AG-3592 12f1d449-4da3-460d-b4f3-9e1232440a8b Not Available Not Available Not Available Not Available 18 -25141 Not Applicable 0 0 Not Available Not Available TCGA-AG-3592-F37964 4F10CE94-C30D-4351-9251-83994FCD1D5D 6 Not Applicable 1035 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 32 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3592 Not Available WITH TUMOR Not Available .96 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-F5-6864 379 Alive T3 N2a M0 Stage IIIB 0 379 74 Rectum TCGA-F5-6864 3546a93b-b279-4615-9d5f-5baa787e487e Not Available Not Available Not Available Not Available 7 -27058 Not Applicable 0 14 Not Available TCGA-F5-6864-D33874;TCGA-F5-6864-D33875 A7C58EE8-6D8E-465B-879A-863167346D8A;591BBBE2-4B58-48F4-B353-932C79B86C0F Not Available;Not Available 23;23 191;191 17;17 5-Fluorouracil;Leucovorin Complete Response;Complete Response 7;7 Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Applicable;Not Applicable Not Available;Not Available Not Available;Not Available NO;NO Chemotherapy;Ancillary Not Available;Not Available Not Available;Not Available Not Available;Not Available NO;NO 2012;2012 NOT HISPANIC OR LATINO TCGA-F5-6864-F33873;TCGA-F5-6864-F63126 12027E4A-E5E6-4DEC-8470-5B1CEC99A5A1;AA29FC62-BE82-4DD6-8C0A-13EE5B35EB9D 23;30 Not Applicable;Not Applicable 379;Not Available Scheduled Follow-up Submission;Scheduled Follow-up Submission Complete Remission/Response;Not Available NO;YES 7;9 NO;Not Available TUMOR FREE;Not Available YES;Not Available Complete Remission/Response;Not Available NO;Not Available Alive;Not Available 2012;2014 FEMALE 157 Rectal Adenocarcinoma Not Available No C20 8140/3 C20.9 YES NO Not Available Not Available Not Available Not Available 4 NO Not Available 10 Not Available NO Not Available 0 Not Available 4 Not Available No 6864 NO TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N2a T3 Not Available YES NO F5 Rectum NO Alive 78 2011 2011 TCGA-CL-4957 425 Alive T3 N1 M0 0 425 79 Not Available TCGA-CL-4957 a2e47568-eb43-4c89-ad7c-dfbaa2ba7e27 Not Available Not Available Not Available Not Available 7 -29081 Not Applicable 0 425 Not Available TCGA-CL-4957-D10094;TCGA-CL-4957-D10096;TCGA-CL-4957-D10097;TCGA-CL-4957-D10095 c60e340b-0248-41fe-80fd-cef4fac101f3;d4aea7da-592a-47ce-ae43-a801599416d4;287ad8e2-f73e-4ece-ab30-2fe789f2d532;001b65f0-aff7-4cb6-bf83-050f9370e6ae Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;7 73;73;73;73 42;42;42;42 Oxaliplatin;Fluorouracil;Leucovorin Calcium;Fluorouracil Not Available;Not Available;Not Available;Not Available 4;4;4;4 3;3;3;3 65;400;400;1200 mg/m2;mg/m2;mg/m2;mg ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available;Not Available IV;IV;IV;IV NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available 2011;2011;2011;2011 HISPANIC OR LATINO TCGA-CL-4957-F10093;TCGA-CL-4957-F68869 6035c913-cd17-4dbb-a96a-7344cabf4d3f;BB9D988B-9616-42C9-97AC-77BAF4223A9E 7;22 Not Applicable;Not Available Not Available;Not Available Not Available;Scheduled Follow-up Submission Not Available;Not Applicable Not Available;NO 4;12 NO;NO Not Available;Unknown YES;YES Not Available;Complete Remission/Response NO;NO Alive;Dead 2011;2014 FEMALE Not Available Rectal Adenocarcinoma Not Available No C20 8140/3 C20.9 YES Not Available Not Available Not Available Not Available Not Available 14 Not Available Not Available 4 Not Available Not Available Not Available Not Available Not Available 2 0 No 4957 Not Available Not Available Not Available Not Available YES Not Available Not Available Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Discrepancy Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N1 T3 Not Available Not Available Not Available CL Rectum Not Available Alive Not Available 2011 2008 TCGA-AG-3909 608 Alive T3 N1 M0 Stage IIIB 0 608 69 Rectum TCGA-AG-3909 769880ae-34d9-405e-8ea7-33ba47cf2dd2 NO Not Available Not Available NO 18 -25537 Not Applicable 0 0 Not Available TCGA-AG-3909-D37656;TCGA-AG-3909-D37657;TCGA-AG-3909-D37658 9844876F-EB16-49BC-86DC-FCCAC4BD3B19;AAB0F90D-B954-464B-9589-2484E0399046;117DFF8F-E037-4B98-8108-AB8562BC27F8 n/a;n/a;n/a 5;5;5 243;243;182 62;62;62 Folinic acid;5-Fluorouracil;Oxaliplatin Complete Response;Complete Response;Complete Response 12;12;12 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2012;2012;2012 Not Available TCGA-AG-3909-F38302 F4B63998-15DD-4D28-8F92-0A49CFD46C76 12 Not Applicable 608 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 35 YES Not Available 5 Not Available Not Available Not Available 2 Not Available 3 Not Available No 3909 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2008 TCGA-AG-A01N 943 Alive T2 N0 M1 Stage IV 0 943 68 Rectum TCGA-AG-A01N 1118490d-75aa-43cc-b2a2-c2af61829ffc NO Not Available Not Available Not Available 15 -25049 Not Applicable 0 31 Not Available TCGA-AG-A01N-D37674;TCGA-AG-A01N-D37675;TCGA-AG-A01N-D37676 8793E6F8-2AE4-419F-82DA-05F1528C6AF6;E059357B-5A89-48CC-B169-E79CDB764464;227136E0-CD9A-4B79-9777-3212A6324483 n/a;n/a;n/a 5;5;5 Not Available;457;Not Available 273;273;273 Capecitabine;Oxaliplatin;Bevacizumab Not Applicable;Partial Response;Not Applicable 12;12;12 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available YES;NO;YES Chemotherapy;Chemotherapy;Targeted Molecular therapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2012;2012;2012 Not Available TCGA-AG-A01N-F38513 5D5D2321-AC02-49D8-90C1-DE6DA5B80533 16 Not Applicable 943 Scheduled Follow-up Submission Partial Remission/Response NO 12 NO WITH TUMOR YES Partial Remission/Response NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 23 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available Yes A01N Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M1 N0 T2 NO NO YES AG Rectum NO Alive Not Available 2011 2009 TCGA-AG-3885 546 Alive T3 N1 M0 Stage IIIB 0 546 71 Rectum TCGA-AG-3885 e5e4aa9f-6015-4d62-a088-69920d7f2500 NO Not Available 0 Not Available 18 -26145 Not Applicable 0 0 Not Available TCGA-AG-3885-D37648;TCGA-AG-3885-D37649 C4BBC4E0-3D66-4633-A05D-4A68AE87C8A7;78CE6B50-B0DA-403C-A9CF-FFF157A9C0CC n/a;n/a 5;5 Not Available;Not Available Not Available;365 Unknown;Zoledronic acid Complete Response;Not Applicable 12;12 Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Applicable;Not Applicable Not Available;Not Available Not Available;Not Available Not Available;YES Chemotherapy;Ancillary Not Available;Not Available Not Available;Not Available Not Available;Not Available NO;NO 2012;2012 Not Available TCGA-AG-3885-F38014 BCAC2361-83FB-4AD8-B897-24DEAB6DD42A 8 Not Applicable 546 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response YES Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 19 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 3 Not Available No 3885 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-3885-R38358 F747E175-7B33-42B7-A077-B3581BBCF094 Not Available 13 91 30 Complete Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2008 TCGA-AG-3901 761 Alive T3 N1 M0 Stage IIIB 0 761 67 Rectum TCGA-AG-3901 1586cb0a-081a-4364-9470-46f9d0f0167d NO Not Available Not Available Not Available 18 -24502 Not Applicable 0 0 Not Available Not Available TCGA-AG-3901-F38022 49E1ECE9-A495-4072-B759-530DA98392DC 20 Not Applicable 761 Scheduled Follow-up Submission Not Applicable NO 8 Unknown Unknown NO Not Available NO Alive 2015 FEMALE Not Available Rectal Mucinous Adenocarcinoma NO No C19 8480/3 C19.9 YES NO Not Available Not Available NO Not Available 20 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 2 Not Available No 3901 Not Available WITH TUMOR Not Available 0.6 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AG-3742 30 Alive T1 N0 M0 Stage I 0 30 85 Rectum TCGA-AG-3742 fbcd7e69-533f-4b6c-9868-162139135b58 NO Not Available Not Available Not Available 18 -31078 Not Applicable 0 30 Not Available Not Available FEMALE Not Available Rectal Adenocarcinoma NO No C18.9 8140/3 C18.9 YES NO Not Available Not Available NO Not Available 18 Not Available Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3742 Not Available WITH TUMOR Not Available 13.78 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T1 NO NO YES AG Rectum Not Available Alive Not Available 2010 2004 TCGA-AG-3906 608 Alive T2 N0 M0 Stage I 0 608 67 Rectum TCGA-AG-3906 ec2abe34-6566-4c2f-8d06-ade2e858b301 NO Not Available Not Available Not Available 18 -24806 Not Applicable 0 0 Not Available Not Available TCGA-AG-3906-F38024 19513288-4BAC-4556-986C-507799ACAD9F 8 Not Applicable 608 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 26 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3906 Not Available WITH TUMOR Not Available 2.4 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum NO Alive Not Available 2010 2008 TCGA-F5-6814 1131 Alive T3 N0 M0 Stage IIA 0 1131 57 Rectum TCGA-F5-6814 8feb0e8f-d09b-437d-8651-0cdecfe776bf NO Not Available Not Available NO 20 -20828 Not Applicable 0 16 Not Available NOT HISPANIC OR LATINO TCGA-F5-6814-F35048;TCGA-F5-6814-F65816 779F082A-7176-4406-8C98-BD5DB0033D21;8CFF640D-DC67-4DDA-908F-023958D4358C 14;30 Not Applicable;Not Applicable 564;1131 Scheduled Follow-up Submission;Scheduled Follow-up Submission Unknown;Complete Remission/Response NO;NO 9;9 NO;NO TUMOR FREE;TUMOR FREE NO;NO Unknown;Complete Remission/Response NO;NO Alive;Alive 2012;2014 MALE 175 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available Not Available Not Available 18 NO Not Available 12 Not Available NO Not Available 0 Not Available 0 0 No 6814 NO TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO F5 Rectum NO Alive 61 2011 2011 TCGA-G5-6572 1432 Dead 0 1432 56 Rectosigmoid Junction TCGA-G5-6572 2cf90e4e-b952-4a77-aaa9-39e4e2e5c4b3 NO Not Available Not Available NO 2 -20475 1432 0 Not Available Not Available NOT HISPANIC OR LATINO TCGA-G5-6572-F15855 d8728ad2-17ed-4ac4-b49d-7c6aad3c4bf3 2 1432 Not Available Scheduled Follow-up Submission Not Available Not Available 9 NO TUMOR FREE NO Not Available NO Dead 2011 MALE 185.4 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 22 NO Not Available 9 Not Available NO Not Available 0 Not Available 0 Not Available No 6572 NO TUMOR FREE Not Available 1.7 YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable Not Available Not Available Not Available NO NO YES G5 Rectum NO Dead 140 2011 2004 TCGA-DC-6158 334 Dead T2 N0 M0 Stage I 0 334 70 Rectum TCGA-DC-6158 0011a67b-1ba9-4a32-a6b8-7850759a38cf NO Not Available 2 NO 26 -25842 Not Applicable 0 212 Not Available NOT HISPANIC OR LATINO TCGA-DC-6158-F14262;TCGA-DC-6158-F21434 fe0149cd-4f9b-42aa-97a9-5abfde320d0b;c88fb7e8-0aaf-4565-a973-a4103dcc9c79 26;13 Not Applicable;334 216;Not Available Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available Not Available;Not Available 7;2 NO;NO TUMOR FREE;TUMOR FREE NO;NO Not Available;Not Available NO;NO Alive;Dead 2011;2012 MALE 160 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 1 NO Not Available 7 Not Available NO Not Available 0 Not Available 0 Not Available No 6158 YES TUMOR FREE Not Available 1.7 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO YES NO DC Rectum YES Alive 71.7 2011 2010 TCGA-AG-3601 0 Alive T4 N1 M0 Stage IIIB 0 0 68 Rectum TCGA-AG-3601 ba902e78-752f-4248-9a59-ea08475c961b NO Not Available Not Available Not Available 18 -24837 Not Applicable 0 0 Not Available Not Available MALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 17 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 2 Not Available No 3601 Not Available WITH TUMOR Not Available 47.92 YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T4 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-F5-6811 979 Alive T3 N0 M0 Stage IIA 0 979 72 Rectosigmoid Junction TCGA-F5-6811 cc2a014b-fb3c-4839-a5fb-6c40e745df1b Not Available Not Available Not Available Not Available 26 -26575 Not Applicable 0 31 Not Available NOT HISPANIC OR LATINO TCGA-F5-6811-F55510 C955DC30-EE36-47C5-B2B9-FE173D6B4105 8 Not Applicable 979 Scheduled Follow-up Submission Complete Remission/Response YES 1 NO TUMOR FREE NO Complete Remission/Response NO Alive 2014 FEMALE 165 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES Not Available Not Available Not Available Not Available Not Available 8 NO NO 8 Not Available YES Not Available 0 Not Available 0 0 No 6811 Not Available TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 Not Available YES NO F5 Rectum NO Alive 88 2011 2011 TCGA-EF-5830 106 Alive T4a N0 M0 Stage IIB 0 106 54 Rectum TCGA-EF-5830 0b6b1937-4024-4f2c-aeca-46387277755f NO Not Available Not Available NO 15 -19802 Not Applicable 0 15 Not Available NOT HISPANIC OR LATINO TCGA-EF-5830-F69008 68AE9B17-D82E-4FC6-8CFA-D8798ADEE747 24 Not Applicable 106 Scheduled Follow-up Submission Not Applicable YES 12 NO Not Available NO Not Applicable NO Alive 2014 MALE 182 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available Not Available NO NO 7 Not Available NO Not Available 1 Not Available Not Available Not Available No 5830 NO TUMOR FREE Not Available Not Available NO Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T4a NO NO YES EF Rectum NO Alive 93 2011 2010 TCGA-AH-6897 804 Alive T2 N0 M0 Stage I 0 804 48 Rectosigmoid Junction TCGA-AH-6897 182fe81e-9c96-4824-8a8a-28f7c498020f Not Available Not Available 30 NO 22 -17536 Not Applicable 0 140 Not Available NOT HISPANIC OR LATINO TCGA-AH-6897-F45570 A1D2E669-7AF0-442D-92CB-4040F8619C46 17 Not Applicable 804 Scheduled Follow-up Submission Complete Remission/Response NO 7 NO TUMOR FREE NO Complete Remission/Response NO Alive 2013 MALE 180.5 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES Not Available Not Available Not Available NO Not Available 14 NO NO 7 Not Available NO Not Available 0 Not Available 0 Not Available No 6897 NO TUMOR FREE Not Available 1.23 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AH Rectum NO Alive 86.4 2011 2010 TCGA-AF-2691 1309 Alive T1 N0 M0 Stage I 0 1309 48 Rectum TCGA-AF-2691 830fd359-abd4-4c99-89e4-2d6bb9ce5637 NO Not Available Not Available NO 28 -17759 Not Applicable 0 323 Not Available NOT HISPANIC OR LATINO TCGA-AF-2691-F2590;TCGA-AF-2691-F41268 ab8576f5-091c-4624-a05c-fe23bb47d532;7020FFED-888A-4FB5-AF5E-D23B31E38E6A 28;14 Not Applicable;Not Applicable 323;1309 Not Available;Scheduled Follow-up Submission Not Available;Complete Remission/Response Not Available;NO 10;3 NO;NO TUMOR FREE;TUMOR FREE NO;NO Not Available;Complete Remission/Response NO;NO Alive;Alive 2010;2013 FEMALE 167.6 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 17 NO Not Available 10 Not Available NO Not Available 0 Not Available 0 Not Available No 2691 Not Available TUMOR FREE Not Available 1.3 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N0 T1 NO YES NO AF Rectum NO Alive 52.4 2010 2009 TCGA-AF-6136 741 Alive T3 N1b MX Stage IIIB 1 199.0 Not Available Unknown 72 Rectosigmoid Junction TCGA-AF-6136 5bc1db25-3e25-44d7-99cb-e31f00cf1d58 Not Available Not Available Not Available NO 12 -26490 Not Applicable 0 232 Not Available TCGA-AF-6136-D31526;TCGA-AF-6136-D31527;TCGA-AF-6136-D31528;TCGA-AF-6136-D31529;TCGA-AF-6136-D31525 6a8a2d9a-dceb-4ed9-8bfc-76a4c6c10c28;54ada04a-3ac3-487d-b98b-814256e83be5;1419103a-d51d-4461-bb13-1a18acce6ed3;b031c881-0b3e-4778-bc63-28d0e2bf4c48;e005c38c-40ff-4493-815b-770c79d550ad Not Available;Not Available;Not Available;Not Available;Not Available 9;9;9;9;11 385;454;454;453;117 209;209;209;209;117 Oxaliplatin;Leucovorin;Fluorouracil;Fluorouracil;Fluorouracil Stable Disease;Stable Disease;Stable Disease;Stable Disease;Unknown 5;5;5;5;5 Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO;NO Chemotherapy;Ancillary;Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO;NO 2012;2012;2012;2012;2012 NOT HISPANIC OR LATINO TCGA-AF-6136-F31524;TCGA-AF-6136-F40235 007f8ef2-68fb-4272-b6f6-2c58ca7efbac;A13C75DA-41ED-4FB4-A7E2-EFA73D2C25F5 4;14 Not Applicable;Not Applicable 468;741 Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Progressive Disease Not Available;NO 5;2 YES;YES NO;NO Not Available;Not Available 199;609 Unknown;Unknown NO;NO Not Available;Not Available Not Available;Not Available YES;YES WITH TUMOR;WITH TUMOR YES;YES Not Available;Progressive Disease YES;YES Alive;Alive 2012;2013 FEMALE 161.3 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES Not Available Not Available Not Available YES MLH1-Expressed;MSH2-Expressed;PMS2-Expressed;MSH6-Expressed 52 YES NO 9 Not Available YES 0 0 5 2 Not Available No 6136 Not Available WITH TUMOR Not Available 18.3 YES Not Available WHITE Not Available Primary Tumor Field TCGA-AF-6136-R31520 4a90eba2-d186-4ac7-b35f-44996abcf93b 1 4 143 104 Not Available 5 28 5040 NO EXTERNAL BEAM Not Applicable ADJUVANT Not Available cGy 2012 Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable MX N1b T3 NO YES NO AF Rectum YES Alive 67.2 2011 2011 TCGA-AG-A036 3562 Alive T3 N2 M0 Stage III 0 3562 71 Rectum TCGA-AG-A036 f2a8deb2-0e2c-4bbd-8fa1-99b7abb2f3aa NO Not Available 1 Not Available 15 -26206 Not Applicable 0 31 Not Available TCGA-AG-A036-D37689 5C971E83-8B85-45AE-86A7-2658BC205B5F n/a 5 215 92 5-Fluorouracil Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 Not Available TCGA-AG-A036-F38517 056C033F-17DB-419C-AC3A-3A1DB7F3971A 16 Not Applicable 3562 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response YES Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 30 Not Available Not Available 6 Not Available Not Available Not Available 0 Not Available 18 Not Available No A036 Not Available WITH TUMOR Not Available 2.2 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-A036-R38369 681D02A8-5853-43DB-892B-D2EDE71E2AE6 Not Available 13 215 92 Complete Response 12 Not Available Not Available NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage III Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N2 T3 NO NO YES AG Rectum Not Available Alive Not Available 2011 2002 TCGA-AF-A56N 360 Alive T3 N0 M0 Stage IIA 0 360 47 Rectum TCGA-AF-A56N 811F3FEB-A5A9-48B1-ACDA-FBB23FCBCF16 Unknown Not Available Not Available NO 11 -17480 Not Applicable 0 138 Not Available TCGA-AF-A56N-D42111;TCGA-AF-A56N-D42114 5A29766B-D0E7-47E8-BB9B-21A9A9E7F331;9BCDA4FD-AF03-4003-9FD6-36343C7BB81C Not Available;Not Available 11;11 95;347 54;159 xeloda;xeloda Complete Response;Complete Response 4;4 Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Applicable;Not Applicable Not Available;Not Available Not Available;Not Available NO;NO Chemotherapy;Chemotherapy Not Available;Not Available Not Available;Not Available Not Available;Not Available NO;NO 2013;2013 NOT HISPANIC OR LATINO TCGA-AF-A56N-F51140 0A37BF85-A860-4A9A-A6C8-A44E2786799F 8 Not Applicable 360 Scheduled Follow-up Submission Complete Remission/Response NO 11 NO TUMOR FREE YES Complete Remission/Response YES Alive 2013 FEMALE 165.1 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES Unknown Not Available Not Available YES MLH1-Expressed;MSH2-Expressed;PMS2-Expressed;MSH6-Expressed 33 NO NO 4 NO NO 0 0 5 0 Not Available No A56N Not Available TUMOR FREE YES 9.5 YES Complete Remission/Response BLACK OR AFRICAN AMERICAN YES Primary Tumor Field TCGA-AF-A56N-R42108 13C9FA18-FACB-43ED-B9E2-B54D13703B9C Not Available 11 95 54 Complete Response 4 28 5040 NO External Not Applicable Not Available Not Available cGy 2013 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO AF Rectum NO Alive 78.1 2013 2012 TCGA-AG-3575 365 Alive T3 N0 M0 Stage II 0 365 51 Rectum TCGA-AG-3575 5daa9f6b-eeba-466f-992b-2bd29fa60e93 NO Not Available 1 Not Available 18 -18932 Not Applicable 0 365 Not Available Not Available TCGA-AG-3575-F37950 C607FFA9-F026-48E8-B561-5437A501D11E 6 Not Applicable 365 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 31 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3575 Not Available Discrepancy Not Available .83 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage II Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2006 TCGA-DY-A1DD 1741 Dead T3 N1 M0 Stage IIIB 0 1741 77 Rectosigmoid Junction TCGA-DY-A1DD 813bb368-9389-4528-9b18-387374bc912f YES Normal Not Available Not Available Not Available -28159 1741 0 1741 1741 NOT HISPANIC OR LATINO TCGA-DY-A1DD-F19086 58653763-6128-40AA-BCF5-01E1D8EF1CC1 2 1741 1741 Scheduled Follow-up Submission Not Available Not Available 12 NO Not Available Not Available Not Available Not Available Dead 2011 FEMALE 156 Rectal Adenocarcinoma Not Available No C19 8140/3 C19.9 YES YES Not Available NO Not Available Not Available 16 Not Available NO 5 Not Available Not Available 0 0 5 1 Not Available No A1DD Not Available Not Available Not Available Not Available YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES DY Rectum Not Available Dead 42 2011 1999 TCGA-F5-6861 1160 Alive T3 N0 M0 Stage IIA 0 1160 60 Rectum TCGA-F5-6861 78499f63-fe28-4b99-9f0e-6002203c4596 NO Not Available Not Available NO 7 -21936 Not Applicable 0 34 Not Available NOT HISPANIC OR LATINO TCGA-F5-6861-F35080;TCGA-F5-6861-F59744 D07B8AE6-9626-434B-BF8B-9ECEA00202FB;26091CBA-9898-45A7-B585-33DDE431C3BA 14;20 Not Applicable;Not Applicable 449;1160 Scheduled Follow-up Submission;Scheduled Follow-up Submission Unknown;Complete Remission/Response NO;NO 9;5 NO;NO TUMOR FREE;TUMOR FREE NO;NO Unknown;Complete Remission/Response NO;NO Alive;Alive 2012;2014 FEMALE 162 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 8 NO Not Available 10 Not Available NO Not Available Not Available Not Available 0 0 No 6861 NO TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO F5 Rectum NO Alive 64 2011 2011 TCGA-AG-3580 244 Alive T1 N0 M0 Stage I 0 244 67 Rectum TCGA-AG-3580 594a52b0-c929-4e50-ae27-7542e32667ae NO Not Available Not Available Not Available 18 -24775 Not Applicable 0 0 Not Available Not Available TCGA-AG-3580-F37955 A616BC22-19E3-4565-A5F9-DB08889B9D83 6 Not Applicable 244 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 22 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available Yes 3580 Not Available WITH TUMOR Not Available .87 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T1 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-CI-6624 1466 Alive T2 N0 M0 Stage I 0 1466 53 Rectosigmoid Junction TCGA-CI-6624 398da5c2-d9f2-4eb4-9813-21009d3ad048 Not Available Not Available Not Available Not Available 15 -19419 Not Applicable 0 144 Not Available NOT HISPANIC OR LATINO TCGA-CI-6624-F69599 62F4B30E-B9F2-43DD-A3B0-2706A54C4A74 14 Not Applicable 1466 Scheduled Follow-up Submission Unknown NO 1 Unknown Unknown Unknown Unknown Unknown Alive 2015 FEMALE Not Available Rectal Adenocarcinoma Not Available No C20 8140/3 C20.9 YES Not Available Not Available Not Available Not Available Not Available Not Available NO Not Available 9 Not Available Not Available Not Available Not Available Not Available Not Available Not Available No 6624 NO Not Available Not Available 7.0 Not Available Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T2 Not Available NO YES CI Rectum NO Alive Not Available 2011 2011 TCGA-AG-3600 184 Alive T3 N2 M0 Stage IIIC 0 184 62 Rectum TCGA-AG-3600 17a8d208-fcf6-4480-945c-848d4234aafd NO Not Available 10 Not Available 18 -22767 Not Applicable 0 0 Not Available TCGA-AG-3600-D37630 69707452-630C-4BFE-A48F-B625078F02D9 Not Available 5 92 31 5-Fluorouracil Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 Not Available TCGA-AG-3600-F37993 962BD6CB-56DF-4352-B79A-FC742A8C6AC0 8 Not Applicable 184 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response YES Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 45 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 31 Not Available No 3600 Not Available WITH TUMOR Not Available 48.85 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-3600-R38354 93B78164-CB0A-482C-943D-B5E038F0297F Not Available 13 92 31 Complete Response 12 Not Available 41 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N2 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AG-A032 1157 Alive T3 N1 M0 Stage IIIB 1 792.0 Not Available Unknown 68 Rectum TCGA-AG-A032 0bb786ee-07cf-4853-9b49-ec95cd14e282 NO Not Available Not Available Not Available 15 -24865 Not Applicable 0 31 Not Available TCGA-AG-A032-D37688 E547F9F9-E8C7-444D-9948-84C39401718F n/a 5 Not Available 458 Bevacizumab Not Applicable 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available YES Targeted Molecular therapy Not Available Not Available Not Available NO 2012 Not Available TCGA-AG-A032-F38516 BDFAE041-B1B1-4165-9E13-7DECD1F78D56 16 Not Applicable 1157 Scheduled Follow-up Submission Partial Remission/Response NO 12 Unknown Unknown Not Available 792 Unknown NO Not Available Not Available YES WITH TUMOR YES Partial Remission/Response YES Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 16 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 2 Not Available No A032 Not Available WITH TUMOR Not Available 7.77 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-A032-R38373 E8E3A0C6-BFF9-4346-B4B4-77958AB2F5DD Not Available 13 92 61 Partial Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES AG Rectum YES Alive Not Available 2011 2007 TCGA-AG-A01L 0 Alive T3 N1 M0 Stage IIIB 0 0 58 Rectum TCGA-AG-A01L 848a5838-8a06-45a9-a3d6-e4ed47b824ab NO Not Available Not Available Not Available 15 -21369 Not Applicable 0 0 Not Available TCGA-AG-A01L-D37673 8D57ECE2-11F5-4F08-8457-0FE7CAE7E643 Not Available 5 212 61 5-Fluorouracil Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 Not Available MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 47 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 2 Not Available No A01L Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-A01L-R38368 3370ED90-BCDB-4646-9AAB-A38E5438CB38 Not Available 13 91 61 Complete Response 12 Not Available Not Available NO External Not Applicable Not Available Not Available Not Available 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES AG Rectum NO Alive Not Available 2011 2009 TCGA-CI-6620 1009 Alive T3 N1 M1 Stage IVA 1 90.0 Not Available Unknown 41 Rectum TCGA-CI-6620 b26143d3-d458-4d5c-8446-fd2f05707352 Not Available Not Available Not Available Not Available 30 -15322 Not Applicable 0 184 Not Available TCGA-CI-6620-D69556;TCGA-CI-6620-D69557;TCGA-CI-6620-D69558 1F45E610-2ED5-4BF2-9A0B-213C8802E4ED;9B427929-3285-4A24-8FDD-0ADFCB371A7B;ED3B3488-DA97-4D97-A0A2-C1E0F5900F16 Not Available;Not Available;Not Available 13;13;13 160;160;160 39;39;39 Leucovorin;Fluorouracil;Oxaliplatin Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease 1;1;1 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Ancillary;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2015;2015;2015 NOT HISPANIC OR LATINO TCGA-CI-6620-F69554 0513D499-31F9-4FC8-BFA0-28D6038FA2DC 13 Not Applicable 1009 Scheduled Follow-up Submission Progressive Disease NO 1 YES NO Not Available 90 Unknown NO Not Available Not Available YES WITH TUMOR YES Progressive Disease NO Alive 2015 FEMALE Not Available Rectal Adenocarcinoma Not Available Yes C20 8140/3 C20.9 YES Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available 11 Not Available Not Available Not Available Not Available Not Available Not Available Not Available No 6620 Not Available WITH TUMOR Not Available Not Available Not Available Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IVA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M1 N1 T3 Not Available NO YES CI Rectum Not Available Alive Not Available 2011 2010 TCGA-AH-6544 1173 Alive T3 N1 M1 0 1173 60 Rectosigmoid Junction TCGA-AH-6544 835cbd02-4dbb-4273-9704-4b5d272493d7 NO Not Available 6 Not Available 21 -21977 Not Applicable 0 15 Not Available TCGA-AH-6544-D58962;TCGA-AH-6544-D58963;TCGA-AH-6544-D58964;TCGA-AH-6544-D72541;TCGA-AH-6544-D72542 A7E20535-8B56-47B9-9317-056575B2B34A;E0872852-6AFB-4304-9F95-06C0DAE1CC66;26178324-9337-4FDE-9138-4CB722F26575;1ED54217-BFD1-4649-BA20-441ACCFBBF6D;135340EA-B051-4018-8B82-1B4FDE8149C5 Not Available;Not Available;Not Available;Not Available;Not Available 29;29;29;13;13 229;365;365;229;229 68;68;243;68;68 Oxaliplatin;Avastin;Xeloda;5-FU;Leucovorin Stable Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease 4;4;4;7;7 Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Ancillary Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO;NO 2014;2014;2014;2015;2015 Not Available TCGA-AH-6544-F58961 A7CC21F2-5D55-42F0-8C9E-55E9BD5B1B48 29 Not Applicable 1173 Scheduled Follow-up Submission Stable Disease NO 4 NO WITH TUMOR YES Stable Disease NO Alive 2014 MALE 177.8 Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES YES 12 YES NO Not Available 20 Not Available NO 7 Not Available Not Available 0 0 5 3 Not Available No 6544 Not Available WITH TUMOR Not Available 2497.4 YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M1 N1 T3 Not Available NO YES AH Rectum Not Available Alive 91 2011 2010 TCGA-AG-A02X 1247 Alive T2 N0 M0 Stage I 0 1247 77 Rectum TCGA-AG-A02X a424bfe7-5518-4c80-83c8-709a34320bc7 NO Not Available Not Available Not Available 15 -28399 Not Applicable 0 1247 Not Available Not Available MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 15 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available No A02X Not Available WITH TUMOR Not Available 8.14 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum YES Alive Not Available 2011 2007 TCGA-AG-3602 0 Alive T3 N2 M0 Stage IIIC 0 0 66 Rectum TCGA-AG-3602 c69dec57-7a84-481b-bcfe-61a771d0a9d1 NO Not Available 9 Not Available 18 -24350 Not Applicable 0 0 Not Available Not Available FEMALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 31 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 5 Not Available No 3602 Not Available WITH TUMOR Not Available 66.9 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N2 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AG-3898 1461 Alive T3 N0 M0 Stage IIA 0 1461 61 Rectum TCGA-AG-3898 5a7d19f9-6be2-45ac-9ffc-11e28594eeee NO Not Available Not Available Not Available 18 -22492 Not Applicable 0 0 Not Available Not Available TCGA-AG-3898-F38021 5F29FB6E-D451-492A-A14A-D14512960128 8 Not Applicable 1461 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO WITH TUMOR NO Not Available NO Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 21 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3898 Not Available WITH TUMOR Not Available 1.98 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2006 TCGA-AG-A020 31 Alive T3 N1 M0 Stage III 0 31 57 Rectum TCGA-AG-A020 19e46a3d-18c5-4927-8501-2265e2d617b8 NO Not Available Not Available Not Available 15 -20851 Not Applicable 0 31 Not Available TCGA-AG-A020-D37679;TCGA-AG-A020-D37680;TCGA-AG-A020-D37681 AD098A28-2DA7-4BED-A331-5AA7358A8D28;3881A04C-1D82-4DD6-B894-53A283C12CBE;D2ADA08C-069D-430C-9642-E1F7DCC0513E n/a;n/a;n/a 5;5;5 212;212;212 31;31;31 Folinic acid;5-Fluorouracil;Oxaliplatin Complete Response;Complete Response;Complete Response 12;12;12 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2012;2012;2012 Not Available FEMALE Not Available Rectal Mucinous Adenocarcinoma NO No C20 8480/3 C20.9 YES NO Not Available Not Available NO Not Available 12 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 1 Not Available No A020 Not Available WITH TUMOR Not Available 1.43 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage III Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES AG Rectum Not Available Alive Not Available 2011 2005 TCGA-G5-6235 1696 Alive T3 N1 MX Stage IIIB 1 1042.0 Not Available Unknown 72 Rectosigmoid Junction TCGA-G5-6235 c2ea7b58-cabd-407e-98ce-6cbf9e4d93e1 NO Not Available Not Available NO 14 -26348 Not Applicable 0 1451 Not Available TCGA-G5-6235-D21956;TCGA-G5-6235-D21953;TCGA-G5-6235-D21955 b0ca40c0-6174-4371-bf39-12d2ff45d079;b59a484b-cd0a-4482-ab1d-4310539df12e;05fe541d-4408-48c0-88e2-865b333fb9e5 Not Available;Not Available;Not Available 7;7;7 187;187;187 33;89;33 Oxaliplatin;Fluorouracil;Leucovorin Not Available;Not Available;Not Available 2;2;2 12;8;12 150;740;720 mg;mg;mg ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable 1;1;1 IV;IV;IV NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available 1880;5968;8848 mg;mg;mg Not Available;Not Available;Not Available 2012;2012;2012 NOT HISPANIC OR LATINO TCGA-G5-6235-F21952 a59aa52d-4943-434b-b870-3dd2e3e46cd4 7 Not Applicable 1696 Scheduled Follow-up Submission Not Available Not Available 2 NO YES Not Available 1042 Unknown NO Not Available Not Available YES TUMOR FREE YES Not Available NO Alive 2012 MALE 169.0 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 13 NO Not Available 7 Not Available NO Not Available 0 Not Available 1 Not Available Yes 6235 NO WITH TUMOR Not Available 1.7 YES Not Available WHITE Not Available R1 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable MX N1 T3 NO NO YES G5 Rectum NO Alive 77.6 2011 2007 TCGA-EI-6885 415 Alive T3 N1b M1 Stage IV 1 295.0 Not Applicable Locoregional Disease 57 Rectosigmoid Junction TCGA-EI-6885 3165bf70-df19-4043-bcfc-9ae92197ef72 NO Not Available 7 NO 21 -21140 Not Applicable 0 160 Not Available TCGA-EI-6885-D29907 b055a1f4-d417-4577-9543-dac2a5baa90d Not Available 30 308 69 oxaliplatinum+5 fluorouracilum Not Available 3 12 Not Available mg/m2 ADJUVANT Not Applicable Not Available IV NO Chemotherapy Not Available Not Available mg Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-6885-F29906 9c177069-a46e-4a81-b825-1197281fba02 30 Not Applicable 415 Scheduled Follow-up Submission Not Available Not Available 3 NO NO Not Available 295 Locoregional Disease YES Not Available Not Applicable YES WITH TUMOR YES Not Available NO Alive 2012 FEMALE 164 Rectal Adenocarcinoma NO No C20 8211/3 C20.9 YES NO Not Available Not Available NO Not Available 13 YES Not Available 7 Not Available NO Not Available 0 Not Available 2 Not Available No 6885 YES WITH TUMOR Not Available 7868.0 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M1 N1b T3 NO YES NO EI Rectum NO Alive 53 2011 2011 TCGA-EI-6917 531 Alive T3 N1 M0 Stage IIIA 0 531 33 Rectum TCGA-EI-6917 0cb21fb0-520f-4105-99ec-697a335115b5 NO Not Available 1 NO 18 -12113 Not Applicable 0 237 Not Available TCGA-EI-6917-D29855 4e8e5e86-a3d0-4b3d-b936-bc4046da5b55 Not Available 30 145 100 5fluorouracil+oxaciplatina+l-folinian discido Not Available 3 Not Available 3120+132,6+312 mg/m2 ADJUVANT Not Applicable Not Available IV NO Chemotherapy Not Available Not Available mg Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-6917-F29856 4991ad3c-b4a2-43c4-ba38-56e1762b511d 30 Not Applicable 531 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE YES Not Available NO Alive 2012 MALE 176 Rectal Adenocarcinoma NO No C20 8255/3 C20.9 YES NO Not Available Not Available NO Not Available 14 NO Not Available 7 Not Available NO Not Available Not Available Not Available 3 Not Available No 6917 NO TUMOR FREE Not Available 2.1 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO YES NO EI Rectum NO Alive 80 2011 2010 TCGA-DC-4745 639 Alive T3 N1a M0 Stage IIIB 0 639 49 Rectosigmoid Junction TCGA-DC-4745 644571e9-b8e6-42f3-a2e4-33bad0fac661 NO Not Available 30 NO 9 -17958 Not Applicable 0 334 Not Available TCGA-DC-4745-D16789;TCGA-DC-4745-D16792;TCGA-DC-4745-D16795;TCGA-DC-4745-D16798;TCGA-DC-4745-D16799 56e97bd0-ae1f-4321-9da2-1c4fcebd711d;3ba36058-d0eb-40b6-b5b6-1a57dc54e5ef;2e038d05-efc6-45e4-b011-af9a6669eda3;abf58812-4c12-4734-ba99-80b3e107572f;5935d581-743c-4b5e-892c-f90ab7754666 Not Available;Not Available;Not Available;Not Available;Not Available 26;26;26;26;26 216;216;216;132;204 62;62;62;62;122 Fluorouracil;Fluorouracil;Leucovorin Calcium;Oxaliplatin;Pegfilgrastim Not Available;Not Available;Not Available;Not Available;Not Available 9;9;9;9;9 12;12;12;6;6 800;2400-2500;800;170;6 mg;mg;mg;mg;mg ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Available;Not Applicable;Not Applicable 1;1;1;1;1 IV;IV;IV;IV;SC NO;NO;NO;NO;NO Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Other, specify in notes Not Available;Not Available;Ancillary;Not Available;Ancillary 9600;29000;9600;1020;36 mg;mg;mg;mg;mg Not Available;Not Available;Not Available;Not Available;Not Available 2011;2011;2011;2011;2011 NOT HISPANIC OR LATINO TCGA-DC-4745-F12832;TCGA-DC-4745-F33823 7fa7a007-05f3-49e2-b899-eded752702d1;F7B5E69F-CC72-493B-B369-945E761D0BD0 9;19 Not Applicable;Not Applicable 334;639 Not Available;Scheduled Follow-up Submission Not Available;Complete Remission/Response Not Available;NO 6;7 NO;NO TUMOR FREE;TUMOR FREE YES;YES Not Available;Complete Remission/Response NO;NO Alive;Alive 2011;2012 FEMALE 165 Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available YES MLH1-Not Expressed;MSH2-Not Expressed;PMS2-Not Expressed;MSH6-Not Expressed 22 NO Not Available 6 Not Available NO Not Available 1 Not Available 1 Not Available No 4745 NO Not Available Not Available 1.6 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1a T3 NO NO YES DC Rectum NO Alive 93.8 2011 2010 TCGA-AG-3594 61 Dead T3 N0 M0 Stage IIA 0 61 77 Rectum TCGA-AG-3594 ca8374a4-ce94-4091-aa9e-44339a7c4b22 NO Not Available 0 Not Available 18 -28277 Not Applicable 0 0 Not Available Not Available TCGA-AG-3594-F37967 D79BC200-C885-4E23-BFA5-839BD9F3CB14 6 61 Not Available Scheduled Follow-up Submission Unknown NO 12 Unknown Unknown NO Not Available NO Dead 2012 MALE Not Available Rectal Mucinous Adenocarcinoma YES No C19 8480/3 C19.9 YES NO Not Available Not Available NO Not Available 25 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3594 Not Available WITH TUMOR Not Available 2.99 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-EI-7002 364 Alive T3 N2 M1 Stage IV 0 364 58 Rectum TCGA-EI-7002 2b1783da-9ede-4590-b96a-6b0eabc8777f NO Not Available 9 NO 21 -21192 Not Applicable 0 84 Not Available TCGA-EI-7002-D29904 cfb19b7d-cb95-4630-a70b-ccae74ce829b Not Available 30 224 67 IRINOTECAN+5-fluorouracilim Not Available 3 12 Not Available mg/m2 ADJUVANT Not Applicable Not Available IV NO Chemotherapy Not Available Not Available mg Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-7002-F29903 1189c8c7-3bbd-49d3-9ef1-3c85e6a88838 30 Not Applicable 364 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE YES Not Available NO Alive 2012 MALE 185 Rectal Adenocarcinoma NO No C20 8211/3 C20.9 YES NO Not Available Not Available NO Not Available 13 YES Not Available 7 Not Available NO Not Available 0 Not Available 7 Not Available No 7002 Not Available WITH TUMOR Not Available 140.0 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M1 N2 T3 NO YES NO EI Rectum NO Alive 93 2011 2011 TCGA-AG-3612 608 Alive T3 N1 M0 Stage IIIB 0 608 55 Rectum TCGA-AG-3612 1543c1da-bde4-41c1-a510-56b62db8cca8 NO Not Available 0 Not Available 18 -20242 Not Applicable 0 0 Not Available TCGA-AG-3612-D37636;TCGA-AG-3612-D37637;TCGA-AG-3612-D37638 C4769825-6F3B-421E-B75C-5FEFBE760F7A;ED6FBE6C-F021-4A62-8F36-809D25748C6B;24C1B6B1-A537-45CC-AFFF-36F91F5F59D9 n/a;n/a;n/a 5;5;5 273;273;212 59;59;59 Folinic acid;5-Fluorouracil;Oxaliplatin Complete Response;Complete Response;Complete Response 12;12;12 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2012;2012;2012 Not Available TCGA-AG-3612-F38007 BF9872B6-16F1-4EDD-8D92-607EB0C962EC 8 Not Applicable 608 Scheduled Follow-up Submission Complete Remission/Response YES 12 NO TUMOR FREE YES Complete Remission/Response NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 32 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 1 Not Available Yes 3612 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2009 TCGA-AH-6643 1314 Dead T3 N2b M0 Stage IIIC 1 1026.0 Not Available Unknown 50 Rectosigmoid Junction TCGA-AH-6643 bd0ddc1e-ba3b-4719-a2fa-776f0475dd8a NO Not Available 4 NO 19 -18273 Not Applicable 0 21 Not Available TCGA-AH-6643-D57835;TCGA-AH-6643-D57836;TCGA-AH-6643-D57837 A3494B7C-E0B1-4449-A8D8-3C4470AF9AB4;8010F585-8B53-441B-9465-DED992A7E34E;85D44224-0FAD-4FD4-B75C-8AFCAF6CBF8D Not Available;Not Available;Not Available 27;27;27 202;202;202 41;41;41 Oxaliplatin;5-FU;Leucovorin Complete Response;Complete Response;Complete Response 3;3;3 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Ancillary Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2014;2014;2014 Not Available TCGA-AH-6643-F57833 E55FEF42-0380-4C61-B1DE-B0916442927F 27 1314 Not Available Scheduled Follow-up Submission Progressive Disease NO 3 NO NO Not Available 1026 Unknown NO Not Available Not Available YES WITH TUMOR YES Complete Remission/Response NO Dead 2014 MALE 180.5 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 15 NO Not Available 7 Not Available YES Not Available 0 Not Available 8 Not Available No 6643 NO TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N2b T3 NO NO YES AH Rectum NO Alive 84.4 2011 2010 TCGA-F5-6465 1506 Alive T3 N0 M0 Stage IIA 0 1506 64 Rectosigmoid Junction TCGA-F5-6465 d7cb062c-898d-4452-8e87-57262162bafa Not Available Not Available Not Available NO 21 -23432 Not Applicable 0 103 Not Available NOT HISPANIC OR LATINO TCGA-F5-6465-F39568;TCGA-F5-6465-F30852;TCGA-F5-6465-F70150 386247D2-707A-4CAF-97BB-8B87CADF2848;EDA9775A-A692-425B-AC8B-B3B937ABF832;84A0CBB0-D302-4860-ADA1-B257F0BECEF2 25;24;28 Not Applicable;Not Applicable;Not Applicable 1141;715;1506 Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission Complete Remission/Response;Not Available;Complete Remission/Response NO;Not Available;NO 1;1;1 NO;NO;NO TUMOR FREE;TUMOR FREE;TUMOR FREE NO;NO;NO Complete Remission/Response;Not Available;Complete Remission/Response NO;NO;NO Alive;Alive;Alive 2013;2014;2015 FEMALE 170 Rectal Adenocarcinoma Not Available No C19 8140/3 C19.9 YES Not Available Not Available Not Available Not Available Not Available 12 NO Not Available 6 Not Available NO Not Available 0 Not Available 0 0 No 6465 NO TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO F5 Rectum NO Alive 62 2011 2010 TCGA-G5-6641 804 Alive T1 N1 MX Stage IIIA 0 804 67 Rectosigmoid Junction TCGA-G5-6641 0a2cb2f9-972c-450c-8b7a-115a4cb93658 NO Not Available Not Available NO 4 -24486 Not Applicable 0 636 Not Available TCGA-G5-6641-D21865;TCGA-G5-6641-D21867;TCGA-G5-6641-D21868 d81354b9-0c34-4fcc-8b3f-e3f107f69534;5bf0d06d-1ace-46e0-a4ca-0994b79721e7;9a002138-e55e-40ed-bc8d-9878e0bdcd74 Not Available;Not Available;Not Available 7;7;7 212;254;254 100;100;100 Oxaliplatin;Fluorouracil;Leucovorin Not Available;Not Available;Not Available 2;2;2 9;12;12 210;980;980 mg;mg;mg ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable 1;1;1 IV;IV;IV NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available 1862;11632;11632 mg;mg;mg Not Available;Not Available;Not Available 2012;2012;2012 NOT HISPANIC OR LATINO TCGA-G5-6641-F21862 86156171-7653-4f55-922b-6f7242b3bf5f 7 Not Applicable 804 Scheduled Follow-up Submission Not Available Not Available 2 NO TUMOR FREE YES Not Available NO Alive 2012 MALE 189.3 Rectal Mucinous Adenocarcinoma NO No C19 8480/3 C19.9 YES NO Not Available Not Available NO Not Available 26 NO Not Available 8 Not Available NO Not Available 0 Not Available 1 Not Available Yes 6641 NO TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable MX N1 T1 NO NO YES G5 Rectum NO Alive 118.6 2011 2009 TCGA-AH-6644 838 Alive T3 NX MX 0 838 73 Rectosigmoid Junction TCGA-AH-6644 d9121e5a-88f2-47a6-a0b1-25735c209e54 Not Available Not Available 30 NO 20 -26892 Not Applicable 0 22 Not Available Not Available TCGA-AH-6644-F42780 05D8E4BD-4800-4F9F-8B8E-3A8692F6FD26 30 Not Applicable 838 Scheduled Follow-up Submission Complete Remission/Response NO 4 NO TUMOR FREE NO Complete Remission/Response NO Alive 2013 MALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES Not Available Not Available Not Available Not Available Not Available 15 NO Not Available 7 Not Available Not Available Not Available 0 Not Available 0 Not Available No 6644 Not Available TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable MX NX T3 Not Available NO YES AH Rectum NO Alive Not Available 2011 2010 TCGA-EI-6513 497 Alive T3 N1 M0 Stage IIIB 0 497 59 Rectosigmoid Junction TCGA-EI-6513 a8a5553c-bfe1-4d5f-aacc-5549ded3f91f NO Not Available Not Available YES 16 -21776 Not Applicable 0 210 Not Available NOT HISPANIC OR LATINO TCGA-EI-6513-F28633 DA6A857E-765B-4124-B509-E58E9CC1F4FA 27 Not Applicable 497 Scheduled Follow-up Submission Not Available Not Available 2 NO TUMOR FREE NO Not Available NO Alive 2012 MALE 175 Rectal Adenocarcinoma NO No C20 8263/3 C20.9 YES NO Not Available Not Available NO Not Available 13 NO Not Available 5 Not Available NO Not Available 0 Not Available 2 0 No 6513 NO TUMOR FREE Not Available 1.0 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO YES NO EI Rectum NO Alive 78 2011 2010 TCGA-CI-6623 1443 Alive T1 N0 M0 Stage I 0 1443 44 Rectum TCGA-CI-6623 acccb105-6439-4b30-a0b9-bb94c7873d4a Not Available Not Available Not Available Not Available 30 -16177 Not Applicable 0 285 Not Available NOT HISPANIC OR LATINO TCGA-CI-6623-F69598 20B550ED-D0CF-403D-BC5D-AEB7B98AAD72 14 Not Applicable 1443 Scheduled Follow-up Submission Unknown NO 1 Unknown Unknown Unknown Unknown Unknown Alive 2015 MALE Not Available Rectal Adenocarcinoma Not Available No C20 8140/3 C20.9 YES Not Available Not Available Not Available Not Available Not Available Not Available NO Not Available 11 Not Available Not Available Not Available Not Available Not Available Not Available Not Available No 6623 NO TUMOR FREE Not Available 5.9 Not Available Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T1 Not Available NO YES CI Rectum NO Alive Not Available 2011 2011 TCGA-AG-3591 1035 Alive T3 N0 M0 Stage IIA 0 1035 66 Rectum TCGA-AG-3591 a2b6246d-2b80-49c5-968b-694b4e8171dc NO Not Available 2 Not Available 18 -24167 Not Applicable 0 0 Not Available TCGA-AG-3591-D37628 08A34556-1CC3-4842-91F9-25E1D7455F1E n/a 5 Not Available Not Available Unknown Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available Not Available Chemotherapy Not Available Not Available Not Available NO 2012 Not Available TCGA-AG-3591-F37962 517F641F-615B-49DF-9E92-D15E5A102F03 6 Not Applicable 1035 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response YES Alive 2012 FEMALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 16 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3591 Not Available WITH TUMOR Not Available 15.72 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-3591-R38352 F8AD5111-4DB0-47DE-9147-176C61D00915 Not Available 13 92 31 Complete Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AG-3883 31 Alive T2 N0 M0 Stage I 0 31 69 Rectum TCGA-AG-3883 b6e6e715-ccc5-474f-860a-a10bf1962936 NO Not Available Not Available Not Available 18 -25415 Not Applicable 0 31 Not Available Not Available MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 15 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3883 Not Available WITH TUMOR Not Available 2.39 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum YES Alive Not Available 2010 2008 TCGA-AG-3727 30 Alive T3 N1 M0 Stage III 0 30 78 Rectum TCGA-AG-3727 e6827400-0d95-46b0-8874-6ce9e9d5011b NO Not Available Not Available Not Available 18 -28641 Not Applicable 0 30 Not Available Not Available FEMALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 25 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 2 Not Available No 3727 Not Available WITH TUMOR Not Available 1.1 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage III Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2006 TCGA-CL-5918 0 Alive T3 N0 MX Stage IIA 0 0 90 Rectosigmoid Junction TCGA-CL-5918 f49a8e1e-d247-4c76-ac3b-ad8e5d6b8d18 NO Not Available 6 NO Not Available -32873 Not Applicable 0 0 Not Available NOT HISPANIC OR LATINO TCGA-CL-5918-F39671 1F90F52C-DD81-4DD2-8072-19D77606209D 29 Not Applicable 0 Scheduled Follow-up Submission Complete Remission/Response NO 1 NO TUMOR FREE NO Complete Remission/Response NO Alive 2013 FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available Not Available Not Available Not Available NO Not Available 6 Not Available NO Not Available Not Available Not Available Not Available Not Available No 5918 NO TUMOR FREE Not Available 2.2 Not Available Not Available WHITE Not Available RX Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable MX N0 T3 NO Not Available Not Available CL Rectum NO Alive Not Available 2011 2008 TCGA-AG-A014 485 Alive T2 N0 M0 Stage I 0 485 86 Rectum TCGA-AG-A014 51c37449-6a2e-4c3d-a7cc-06f901e1224f NO Not Available Not Available Not Available 15 -31718 Not Applicable 0 485 Not Available Not Available MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 15 NO Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available Yes A014 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum NO Alive Not Available 2011 2009 TCGA-AF-3914 1146 Alive T3 N2a M0 Stage IIIB 1 846.0 Not Applicable Locoregional Disease 39 Rectosigmoid Junction TCGA-AF-3914 3f2ca278-c74a-4aa7-b029-189d9d0b510c NO Not Available Not Available NO 28 -14426 Not Applicable 0 265 Not Available TCGA-AF-3914-D10865;TCGA-AF-3914-D10888;TCGA-AF-3914-D10886;TCGA-AF-3914-D10887;TCGA-AF-3914-D10864;TCGA-AF-3914-D41485;TCGA-AF-3914-D41486;TCGA-AF-3914-D41487;TCGA-AF-3914-D41488;TCGA-AF-3914-D41489 742fb3eb-c8eb-4377-ad4b-8f106d302e97;9f639bf0-67cc-4ca3-a738-c7f03a214b21;caf0a7a9-d006-46fa-9810-3cb754a26c74;70ef1e70-9652-476a-a268-1280652bb1a8;359d8f95-b037-463b-bebb-679c31c0ef3e;AC84D228-12BE-44DA-A004-F09C1B574F03;9BF0B463-F451-4BB4-BB19-1675656AE60F;DB0F22AA-0122-4C85-9E00-07A45715A0B0;E946FC49-AEB3-4A51-B943-CDA7CC4A7A31;A35156FA-AFFB-498C-AE11-E35ECC46908E Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available 28;28;28;28;28;19;19;19;19;19 294;296;294;294;105;1134;1022;1022;1022;1024 133;133;133;133;61;924;924;924;924;924 oxaliplatin;5 FU;Leucovorin;5 FU;5 FU;Bevacizumab;Leucovorin;Oxaliplatin;Fluorouracil;Fluorouracil IV Continuous infusion over 46 hours Not Available;Not Available;Not Available;Not Available;Not Available;Clinical Progressive Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease 4;4;4;4;4;3;3;3;3;3 12;12;12;12;7;Not Available;Not Available;Not Available;Not Available;Not Available 118-150;3330-4416;50-750;555-736;200-410 daily;Not Available;Not Available;Not Available;Not Available;Not Available mg;mg;mg;mg;mg;Not Available;Not Available;Not Available;Not Available;Not Available ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;Not Available;Not Available;Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable 2;2;2;2;1;Not Available;Not Available;Not Available;Not Available;Not Available IV;IV;IV;IV;IV;Not Available;Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO;NO;NO;NO;NO;NO;NO Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Ancillary;Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available 1643;47,508;3150;7918;12265;Not Available;Not Available;Not Available;Not Available;Not Available mg;mg;mg;mg;mg;Not Available;Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available;Not Available;NO;NO;NO;NO;NO 2011;2011;2011;2011;2011;2013;2013;2013;2013;2013 NOT HISPANIC OR LATINO TCGA-AF-3914-F10221;TCGA-AF-3914-F41446;TCGA-AF-3914-F41483 2e4c493b-8ab4-4702-9df5-76ab606c57f8;E90AF3AA-E606-4766-8F4E-8E25E398E626;E26202AA-E4B0-4EE7-A8CA-4ED7109D9DA2 3;19;19 Not Applicable;Not Applicable;Not Applicable 390;1146;1146 Not Available;Additional New Tumor Event;Additional New Tumor Event Not Available;Progressive Disease;Progressive Disease Not Available;NO;NO 5;3;3 None;YES;YES None;NO;NO None;869;Not Available None;846;846 None;Locoregional Disease;Unknown None;YES;NO None;Not Available;Not Available None;Not Applicable;Not Available NO;YES;YES TUMOR FREE;WITH TUMOR;WITH TUMOR YES;YES;YES Not Available;Complete Remission/Response;Complete Remission/Response YES;YES;YES Alive;Alive;Alive 2011;2013;2013 MALE 172.7 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 55 YES NO 10 Not Available NO 0 0 5 5 Not Available No 3914 Not Available TUMOR FREE Not Available 1.4 YES Not Available WHITE Not Available Primary Tumor Field TCGA-AF-3914-R2587 6db0b8bc-4a5b-422b-bcb1-59a594d938ba 1 28 104 61 Not Available 10 30 5400 NO EXTERNAL BEAM Not Applicable ADJUVANT Not Available cGy 2010 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N2a T3 NO YES NO AF Rectum YES Alive 64.2 2010 2010 TCGA-AG-3881 579 Alive T3 N0 M0 Stage IIA 0 579 83 Rectum TCGA-AG-3881 b6ba7313-8e91-4c39-8629-db3e96f4c556 NO Not Available Not Available Not Available 18 -30467 Not Applicable 0 0 Not Available Not Available TCGA-AG-3881-F38012 CB5CC182-6E3F-4A74-A3A6-AFC8DAF02855 8 Not Applicable 579 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE Not Available Not Available NO No C80.1 8480/3 C80.9 YES NO Not Available Not Available NO Not Available 30 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3881 Not Available WITH TUMOR Not Available 16 YES Not Available Not Available Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2008 TCGA-AG-A01Y 0 Alive T3 N0 M0 Stage II 0 0 49 Rectum TCGA-AG-A01Y a91f7a8c-e0fe-403a-9ef0-f7679b2761cc NO Not Available Not Available Not Available 15 -18112 Not Applicable 0 0 Not Available TCGA-AG-A01Y-D37678 F99733D4-0119-416D-BCC9-791AD546EB61 n/a 5 151 31 5-Fluorouracil Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 Not Available FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 17 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available No A01Y Not Available WITH TUMOR Not Available 5.85 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-A01Y-R38371 0F9BBF5E-5992-4949-8E8C-CD0B31753B6F Not Available 13 121 62 Complete Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage II Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum Not Available Alive Not Available 2011 2004 TCGA-AG-3574 91 Dead T3 N0 M0 Stage II 0 91 89 Rectum TCGA-AG-3574 0eda7373-8335-455f-b90a-8c3540f28088 NO Not Available Not Available NO 18 -32781 Not Applicable 0 0 Not Available Not Available TCGA-AG-3574-F37944 19DCF384-411F-4CA9-B8B8-E2D42800C04A 6 91 Not Available Scheduled Follow-up Submission Unknown NO 12 Unknown Unknown NO Not Available NO Dead 2012 FEMALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 18 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3574 Not Available WITH TUMOR Not Available 4.59 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage II Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2005 TCGA-AG-4015 0 Alive T3 N0 M0 Stage IIA 0 0 85 Rectum TCGA-AG-4015 1388bba1-02ba-40df-93e5-c3d58b7bbae0 NO Not Available Not Available Not Available 18 -31291 Not Applicable 0 0 Not Available Not Available FEMALE Not Available Rectal Adenocarcinoma NO No C18.9 8140/3 C18.9 YES NO Not Available Not Available NO Not Available 24 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 4015 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2009 TCGA-AG-3608 485 Alive T3 N0 M0 Stage IIA 0 485 79 Rectum TCGA-AG-3608 c3760fb2-3b8a-4251-a189-21d56fba5017 NO Not Available 0 Not Available 18 -29008 Not Applicable 0 0 Not Available Not Available TCGA-AG-3608-F37999 A5563A17-C406-4C7F-A3B4-06B121205E6F 8 Not Applicable 485 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 16 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3608 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2008 TCGA-AG-4022 1400 Alive T3 N0 M0 Stage II 0 1400 59 Rectum TCGA-AG-4022 9084b672-8e65-4b7f-a256-32fd35aa8ab5 NO Not Available Not Available Not Available 18 -21823 Not Applicable 0 30 Not Available TCGA-AG-4022-D37665 BA0BE627-3B95-403A-954D-635201C79CD6 Not Available 5 153 61 5-Fluorouracil Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 Not Available TCGA-AG-4022-F38320 C27D26C8-5EE2-4623-855A-329C85715A5B 12 Not Applicable 1400 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response YES Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 12 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 4022 Not Available WITH TUMOR Not Available 1.03 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-4022-R38364 22465234-5910-4156-97D3-DB3DC8195628 Not Available 13 153 122 Complete Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage II Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2006 TCGA-DC-5337 792 Alive T1 N0 M0 Stage I 0 792 69 Rectosigmoid Junction TCGA-DC-5337 016c9c14-4c88-49f5-a11a-dd4bc282f11e NO Not Available 35 NO 3 -25202 Not Applicable 0 304 304 NOT HISPANIC OR LATINO TCGA-DC-5337-F11065;TCGA-DC-5337-F20427;TCGA-DC-5337-F37186 541a1401-c6ec-4c84-b5db-9db899663e57;07fcffc8-aaff-44af-9e9e-b11080d91515;CB413DCF-CEFD-4662-992F-E2EE74C49E46 3;Not Available;29 Not Applicable;Not Applicable;Not Applicable 304;457;792 Not Available;Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available;Unknown Not Available;Not Available;NO 5;1;11 NO;NO;NO Discrepancy;TUMOR FREE;TUMOR FREE NO;NO;NO Not Available;Not Available;Unknown NO;NO;NO Alive;Alive;Alive 2011;2012;2012 MALE 165 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 18 NO Not Available 5 Not Available NO Not Available 0 Not Available 0 Not Available No 5337 NO TUMOR FREE Not Available 2 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T1 NO YES NO DC Rectum NO Alive 69.4 2011 2010 TCGA-AF-2690 524 Dead T3 N2 M0 Stage IIIC 0 524 76 Rectum TCGA-AF-2690 368fd5c9-cd4b-4326-a47b-4d72938cfb8f NO Not Available Not Available NO 3 -28119 Not Applicable 0 358 Not Available NOT HISPANIC OR LATINO TCGA-AF-2690-F7026;TCGA-AF-2690-F13123 2490a4e1-7e5b-4858-bffe-e1302ccc2937;3fd6b428-d0ee-43ee-aaf2-75ad6733a537 3;20 Not Applicable;524 358;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available 2;6 NO;Not Available TUMOR FREE;Not Available NO;Not Available Not Available;Not Available NO;Not Available Alive;Dead 2011;2011 FEMALE 160 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available Not Available Not Available 24 YES Not Available 2 Not Available YES Not Available 1 Not Available 3 Not Available No 2690 Not Available TUMOR FREE Not Available 4.2 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N2 T3 NO YES NO AF Rectum YES Alive 54.5 2011 2009 TCGA-F5-6702 869 Dead T3 N1 M1 Stage IVA 1 368.0 Not Available Unknown 71 Rectosigmoid Junction TCGA-F5-6702 f1ce4b5f-55d0-4989-a5f3-6b6e591538b2 Not Available Not Available Not Available NO 31 -26123 Not Applicable 0 66 Not Available TCGA-F5-6702-D46350;TCGA-F5-6702-D46351;TCGA-F5-6702-D46352 AE38DEA3-6C5A-423C-B49F-86D4DCE40ED9;4A439625-FA84-45EC-817B-67C23AFE1E37;A119CEAA-1B12-4770-B8B6-D4D1D7A38F0F Not Available;Not Available;Not Available 6;6;6 641;641;551 370;370;340 5-Fluorouracil;Polyplatillen;Oxaliplatin Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease 8;8;8 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2013;2013;2013 NOT HISPANIC OR LATINO TCGA-F5-6702-F46648;TCGA-F5-6702-F31161 96B57819-168C-4C4E-A5BB-66664450A232;DE208906-8BA5-4980-BD0B-7EFF18DBA78A 13;6 869;Not Applicable Not Available;452 Scheduled Follow-up Submission;Scheduled Follow-up Submission Progressive Disease;Not Available NO;Not Available 8;8 YES;YES NO;NO Not Available;Not Available 368;368 Unknown;Unknown NO;NO Not Available;Not Available Not Available;Not Available YES;YES WITH TUMOR;WITH TUMOR NO;NO Progressive Disease;Not Available NO;NO Dead;Alive 2013;2013 MALE 172 Rectal Adenocarcinoma Not Available No C19 8140/3 C19.9 YES Not Available Not Available Not Available Not Available Not Available 12 NO Not Available 8 Not Available NO Not Available 1 Not Available 1 Not Available No 6702 NO WITH TUMOR Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IVA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M1 N1 T3 NO YES NO F5 Rectum NO Alive 76 2011 2010 TCGA-AG-3726 243 Alive T2 N0 M0 Stage I 0 243 63 Rectum TCGA-AG-3726 21e8c2b7-3a80-4b7e-acec-6ff863f15324 NO Not Available Not Available Not Available 18 -23345 Not Applicable 0 243 Not Available Not Available TCGA-AG-3726-F38009 870C0B80-2D08-465E-BE2B-B7C27FD27218 8 Not Applicable 243 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 34 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3726 Not Available Discrepancy Not Available 3.98 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum NO Alive Not Available 2010 2006 TCGA-AG-3583 610 Dead T3 N2 M1 Stage IV 0 610 66 Rectum TCGA-AG-3583 5af7b4eb-8314-41ce-ab2b-f98054a78a8b NO Not Available Not Available Not Available 18 -24107 Not Applicable 0 61 Not Available Not Available TCGA-AG-3583-F37959 F861BB3F-7736-4CDE-B4C6-00496512B52A 6 610 Not Available Scheduled Follow-up Submission Unknown NO 12 Unknown Unknown NO Not Available NO Dead 2012 MALE Not Available Rectal Mucinous Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 34 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 9 Not Available No 3583 Not Available WITH TUMOR Not Available 90.73 YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M1 N2 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2008 TCGA-AG-3878 30 Alive T2 N0 M0 Stage I 0 30 64 Rectum TCGA-AG-3878 fdeeff8e-1328-42a4-aca0-a03b97421f1e NO Not Available Not Available Not Available 18 -23527 Not Applicable 0 30 Not Available Not Available MALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 15 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3878 Not Available WITH TUMOR Not Available 1.15 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-EI-6510 556 Alive T2 N0 MX 0 556 77 Rectosigmoid Junction TCGA-EI-6510 093ca3a7-f545-468a-85ed-a35c3da03628 NO Not Available 29 NO 9 -28328 Not Applicable 0 14 Not Available NOT HISPANIC OR LATINO TCGA-EI-6510-F28933 deaacf40-9e9d-4232-bd5d-0ff4ff7bc80d 2 Not Applicable 556 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE 150 Rectal Adenocarcinoma Not Available No C20 8263/3 C20.9 YES NO Not Available Not Available Not Available Not Available 3 NO Not Available 6 Not Available YES Not Available 0 Not Available 0 Not Available No 6510 YES TUMOR FREE Not Available 11.2 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Discrepancy Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable MX N0 T2 Not Available YES NO EI Rectum NO Alive 59 2011 2010 TCGA-AG-3605 30 Alive T3 N1 M1 Stage IV 0 30 85 Rectum TCGA-AG-3605 a744d4a3-f99a-46ce-9b3f-8ee8835e67ec NO Not Available Not Available Not Available 18 -31078 Not Applicable 0 30 Not Available Not Available FEMALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 13 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 3 Not Available No 3605 Not Available WITH TUMOR Not Available 23.09 YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M1 N1 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2008 TCGA-AG-A01J 31 Alive T3 N0 M0 Stage IIA 0 31 59 Rectum TCGA-AG-A01J a18acb1d-403a-4802-8efb-9085e006f4c5 NO Not Available 1 Not Available 15 -21581 Not Applicable 0 31 Not Available Not Available FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 23 NO Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available No A01J Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2011 2009 TCGA-AF-2693 1155 Alive T2 N0 MX Stage I 0 1155 75 Sigmoid Colon TCGA-AF-2693 2faf928d-453a-4d07-b058-b5d4e1d13845 NO Not Available Not Available NO 6 -27443 Not Applicable 0 581 Not Available NOT HISPANIC OR LATINO TCGA-AF-2693-F13591;TCGA-AF-2693-F38391 f7db3277-60f7-40fe-adb7-15a4068bc2b8;20699C1C-39C6-44B3-ADBA-C5E93E7B1B10 6;13 Not Applicable;Not Applicable 581;1155 Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Applicable Not Available;NO 7;12 NO;NO TUMOR FREE;TUMOR FREE NO;Not Available Not Available;Not Available NO;Not Available Alive;Alive 2011;2012 MALE 180.3 Not Available NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 30 NO Not Available 7 Not Available NO Not Available 0 Not Available 0 Not Available No 2693 Not Available TUMOR FREE Not Available 4.0 YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable MX N0 T2 NO YES NO AF Not Available NO Alive 107.6 2011 2009 TCGA-CI-6622 1362 Alive T4 N0 M0 Stage IIB 0 1362 74 Rectum TCGA-CI-6622 bd6877a8-06b4-4b95-bed2-15c524068f21 Not Available Not Available Not Available Not Available 15 -27336 Not Applicable 0 212 Not Available TCGA-CI-6622-D69594;TCGA-CI-6622-D69595;TCGA-CI-6622-D69596;TCGA-CI-6622-D69597 456BA3A9-364D-4109-AB4E-6E5E75B906F2;852704E9-6A87-4723-A643-5414DEE6DAEC;8DD9165C-7657-44D3-9DB9-AF09646B5A24;7E3E8841-F487-467D-AFFE-BA3623C3803B Not Available;Not Available;Not Available;Not Available 14;14;14;14 97;269;269;269 65;116;116;116 Fluorouracil;Leuocvorin;Fluorouracil;Oxaliplatin Unknown;Unknown;Unknown;Unknown 1;1;1;1 Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO 2015;2015;2015;2015 NOT HISPANIC OR LATINO TCGA-CI-6622-F69592 2C2E61F1-9F41-4D75-93C7-45E441A38817 14 Not Applicable 1362 Scheduled Follow-up Submission Unknown NO 1 Unknown Unknown YES Unknown YES Alive 2015 MALE Not Available Rectal Adenocarcinoma Not Available No C20 8140/3 C20.9 YES Not Available Not Available Not Available Not Available Not Available 24 YES Not Available 9 Not Available Not Available Not Available Not Available Not Available 0 Not Available No 6622 YES TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available Unknown TCGA-CI-6622-R69593 019A3A30-B70F-488D-8F91-8CECCDF7ECA7 Not Available 14 97 65 Unknown 1 Not Available Not Available NO Unknown Not Applicable Not Available Not Available Not Available 2015 Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T4 Not Available NO YES CI Rectum YES Alive Not Available 2011 2010 TCGA-DC-5869 943 Alive T3 N1a M0 Stage IIIB 0 943 62 Rectum TCGA-DC-5869 cd05d121-f107-4c8e-95a8-153a84f5134a NO Not Available 14 NO 26 -22676 Not Applicable 0 153 Not Available NOT HISPANIC OR LATINO TCGA-DC-5869-F14251;TCGA-DC-5869-F20518;TCGA-DC-5869-F44744 77dda678-f40a-4512-8e0e-a1ce30b3bfc9;bafb8fb8-690f-46d8-9155-7527fd6c33f3;B69695AC-9228-44DB-80CB-3DB66991DE1B 26;16;26 Not Applicable;Not Applicable;Not Applicable 153;395;943 Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available;Not Applicable Not Available;Not Available;NO 7;1;6 NO;NO;NO TUMOR FREE;TUMOR FREE;TUMOR FREE NO;NO;NO Not Available;Not Available;Not Applicable NO;NO;NO Alive;Alive;Alive 2011;2012;2013 FEMALE 170 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 19 NO Not Available 7 Not Available NO Not Available 0 Not Available 1 Not Available No 5869 NO TUMOR FREE Not Available 3.6 YES Not Available BLACK OR AFRICAN AMERICAN Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1a T3 NO YES NO DC Rectum NO Alive 62.4 2011 2010 TCGA-CI-6621 419 Alive T3 N1 MX Stage IIIB 0 419 63 Rectum TCGA-CI-6621 156cb6c6-b5d4-4ea9-9495-fc972cf9c84a Not Available Not Available Not Available Not Available 9 -23240 Not Applicable 0 0 Not Available NOT HISPANIC OR LATINO TCGA-CI-6621-F69555 953D756D-AFF0-4FBE-BF41-2AD8F944E27B 13 Not Applicable 419 Scheduled Follow-up Submission Unknown NO 1 Unknown Unknown YES Unknown Unknown Alive 2015 MALE Not Available Rectal Adenocarcinoma Not Available No C20 8140/3 C20.9 YES Not Available Not Available Not Available Not Available Not Available 2 Not Available Not Available 1 Not Available Not Available Not Available Not Available Not Available 0 Not Available No 6621 Not Available Not Available Not Available Not Available YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable MX N1 T3 Not Available NO YES CI Rectum Not Available Alive Not Available 2012 2010 TCGA-AG-3893 1065 Alive T3 N1 M0 Stage IIIB 0 1065 74 Rectum TCGA-AG-3893 add567b7-29ef-4122-8a54-57d36f735e78 NO Not Available Not Available Not Available 18 -27272 Not Applicable 0 30 Not Available TCGA-AG-3893-D37653;TCGA-AG-3893-D37654 D8A5AC42-4F51-4626-BFAB-BF6CD4C44D3C;1680F252-BB88-454F-B1CC-FE1038F33269 n/a;n/a 5;5 245;245 61;61 Folinic acid;5-Fluorouracil Complete Response;Complete Response 12;12 Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Applicable;Not Applicable Not Available;Not Available Not Available;Not Available NO;NO Chemotherapy;Chemotherapy Not Available;Not Available Not Available;Not Available Not Available;Not Available NO;NO 2012;2012 Not Available TCGA-AG-3893-F38019 2F3D7FD0-D5D2-4D85-8DB3-626B668281D1 8 Not Applicable 1065 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response NO Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 14 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 1 Not Available No 3893 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T3 NO NO YES AG Rectum Not Available Alive Not Available 2010 2009 TCGA-DY-A1H8 992 Dead T2 N1 M0 Stage IIIA 0 992 77 Rectum TCGA-DY-A1H8 c2395f04-e248-4091-855d-802b1b871f29 NO Not Available Not Available Not Available Not Available -28459 992 0 992 992 NOT HISPANIC OR LATINO TCGA-DY-A1H8-F19088 3B7C3CF1-2960-4E6F-B34C-DCC36970CBF5 2 992 992 Scheduled Follow-up Submission Not Available Not Available 12 NO Not Available Not Available Not Available Not Available Dead 2011 FEMALE 160 Rectal Adenocarcinoma Not Available No C20 8140/3 C20.9 YES YES 12 YES Not Available Not Available 7 Not Available Not Available 5 Not Available Not Available 0 0 0 1 Not Available No A1H8 Not Available Not Available Not Available Not Available YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIA Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N1 T2 NO NO YES DY Rectum Not Available Dead 40 2011 2000 TCGA-AG-A011 1126 Alive T3 N0 M0 Stage IIA 0 1126 80 Rectum TCGA-AG-A011 3be106bc-ba42-4c70-9b50-697d89db617d NO Not Available 1 Not Available 15 -29463 Not Applicable 0 0 Not Available Not Available TCGA-AG-A011-F38509 1FB047EF-E293-40B1-BA39-EDB3780DCBA0 16 Not Applicable 1126 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 14 NO Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available No A011 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2011 2009 TCGA-DT-5265 384 Alive T3 N0 M0 Stage II 0 384 51 Rectum TCGA-DT-5265 3f10de1e-c8ce-415e-b4e1-e50901686a2f Not Available Not Available Not Available Not Available 9 -18669 Not Applicable 0 8 Not Available NOT HISPANIC OR LATINO TCGA-DT-5265-F20335;TCGA-DT-5265-F71902 dbb7e402-4f8a-4699-9784-7ba6ea15c8fa;FCD1BF2E-EC38-4BD0-9B8A-B9500AC8BDEF 9;31 Not Applicable;Not Applicable 161;384 Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Complete Remission/Response Not Available;NO 1;3 NO;NO Not Available;TUMOR FREE NO;NO Not Available;Complete Remission/Response YES;YES Alive;Alive 2012;2015 MALE Not Available Rectal Mucinous Adenocarcinoma Not Available No C20 8480/3 C20.9 YES Not Available Not Available Not Available Not Available Not Available Not Available Not Available Not Available 8 Not Available Not Available Not Available Not Available Not Available Not Available Not Available No 5265 Not Available TUMOR FREE Not Available Not Available NO Not Available ASIAN Not Available RX Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage II Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 Not Available YES NO DT Rectum Not Available Alive Not Available 2011 2010 TCGA-F5-6812 1110 Alive T3 N0 M0 Stage IIA 0 1110 67 Rectum TCGA-F5-6812 e5d7bbd4-4f38-4a5a-9966-f44f8a15a10e NO Not Available Not Available NO 31 -24490 Not Applicable 0 20 Not Available NOT HISPANIC OR LATINO TCGA-F5-6812-F35402;TCGA-F5-6812-F41123;TCGA-F5-6812-F62653 1B6F4C98-4EE1-43C8-99F8-C34B07598DE1;6AE9B448-631F-489D-A13C-2DB49A5E1107;222B6E6D-A861-4EF8-A14A-04D1383A419C 26;12;23 Not Applicable;Not Applicable;Not Applicable 378;742;1110 Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission Complete Remission/Response;Complete Remission/Response;Complete Remission/Response NO;NO;NO 9;3;7 NO;NO;NO TUMOR FREE;TUMOR FREE;TUMOR FREE NO;NO;NO Complete Remission/Response;Complete Remission/Response;Complete Remission/Response NO;NO;NO Alive;Alive;Alive 2012;2013;2014 MALE 188 Rectal Adenocarcinoma NO No C49.4 8140/3 C49.4 YES NO Not Available Not Available NO Not Available 1 NO Not Available 8 Not Available NO Not Available Not Available Not Available 0 0 No 6812 NO TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO F5 Rectum NO Alive 90 2011 2011 TCGA-AF-5654 512 Dead T2 N0 M0 Stage I 0 512 73 Rectosigmoid Junction TCGA-AF-5654 5d4b9087-fa7b-47b8-9b12-adc0dd1cf17c NO Not Available Not Available NO 16 -26738 Not Applicable 0 257 257 NOT HISPANIC OR LATINO TCGA-AF-5654-F12868;TCGA-AF-5654-F32800 f3561c4f-56df-488c-80fc-64cdd590977e;3B0DEBF6-962E-4F3A-91EE-5B2F71D13608 10;12 Not Applicable;512 257;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available 6;6 NO;NO TUMOR FREE;TUMOR FREE NO;Not Available Not Available;Not Available NO;Not Available Alive;Dead 2011;2012 FEMALE 165 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available YES MLH1-Expressed;MSH2-Expressed;PMS2-Expressed;MSH6-Expressed 24 NO NO 5 Not Available NO 0 0 5 0 Not Available No 5654 Not Available TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N0 T2 NO YES NO AF Rectum NO Alive 96.6 2011 2010 TCGA-AH-6903 592 Alive T3 N1b M0 Stage IIIB 0 592 46 Rectosigmoid Junction TCGA-AH-6903 1e89c189-7c8a-44c9-9b0f-2f625a285003 NO Not Available 45 NO 26 -17030 Not Applicable 0 55 Not Available TCGA-AH-6903-D45595;TCGA-AH-6903-D45596;TCGA-AH-6903-D45597 0136A943-A156-450D-89CE-22B658D58AED;3AC71EE5-4B1E-4DBE-856A-2B4841E4EDEE;A49CFDD2-967B-4FC3-8902-594DAA1A2F3A Not Available;Not Available;Not Available 17;17;17 228;228;228 70;70;70 5-FU;Oxaliplatin;Leucovorin Complete Response;Complete Response;Complete Response 7;7;7 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Ancillary Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;Not Available 2013;2013;2013 NOT HISPANIC OR LATINO TCGA-AH-6903-F45564 F7DEF277-33CB-4D2A-8EBC-A4BD9699894B 17 Not Applicable 592 Scheduled Follow-up Submission Complete Remission/Response NO 7 NO TUMOR FREE YES Complete Remission/Response NO Alive 2013 MALE 183 Rectal Mucinous Adenocarcinoma NO No C19 8480/3 C19.9 YES NO Not Available Not Available NO Not Available 18 NO Not Available 7 Not Available NO Not Available 0 Not Available 3 0 No 6903 NO TUMOR FREE Not Available 3.51 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1b T3 NO YES NO AH Rectum NO Alive 74.8 2011 2010 TCGA-AF-3400 1049 Alive T3 N0 M0 Stage IIA 0 1049 54 Rectosigmoid Junction TCGA-AF-3400 cbcb2141-b415-4410-8dd7-2a3cd3980a19 NO Not Available Not Available YES 1 -19826 Not Applicable 0 387 Not Available TCGA-AF-3400-D2753;TCGA-AF-3400-D2847;TCGA-AF-3400-D2850;TCGA-AF-3400-D2833;TCGA-AF-3400-D2800 3ec1df07-49b6-45d9-abb2-137d5d95525f;2a24fcad-f207-47b7-87cf-f710d38df559;a2e12b5b-e00e-4614-aaa9-973b603d189c;f5420dc8-d394-4f7f-9848-008df8cbc84b;0e287f64-1843-4bfa-a0e8-19be31c3cb81 Not Available;Not Available;Not Available;Not Available;Not Available 3;4;4;4;4 137;358;360;358;358 97;185;185;185;185 5FU;5FU;5-FU;Oxaliplatin;Leucovorin Not Available;Not Available;Not Available;Not Available;Not Available 11;11;11;11;11 6;11;11;11;11 459-470;612-832;3672-4992;130-177;600-850 mg;mg;mg;mg;mg ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable 1;2;2;2;2 IV;IV;IV;IV;IV NO;NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes Not Available;Not Available;Not Available;Not Available;Ancillary 14005;7300;44067;1551;6850 mg;mg;mg;mg;mg Not Available;Not Available;Not Available;Not Available;Not Available 2010;2010;2010;2010;2010 NOT HISPANIC OR LATINO TCGA-AF-3400-F2622;TCGA-AF-3400-F38603 1813c9fe-91a4-4dcb-b524-75a8fe9f84f6;B0E9C198-7E07-4627-9CD3-1E1DDF9F2EAD 1;18 Not Applicable;Not Applicable 387;1049 Not Available;Scheduled Follow-up Submission Not Available;Complete Remission/Response Not Available;NO 11;12 NO;NO TUMOR FREE;TUMOR FREE YES;Not Available Not Available;Not Available YES;Not Available Alive;Alive 2010;2012 MALE 177.8 Rectal Mucinous Adenocarcinoma NO No C19 8480/3 C19.9 YES NO Not Available Not Available NO Not Available 32 NO NO 11 Not Available NO 0 1 5 0 Not Available No 3400 Not Available TUMOR FREE Not Available 2.8 YES Not Available WHITE Not Available Primary Tumor Field TCGA-AF-3400-R2623 35b41ef3-8733-4bf5-92d6-7adcadd2c43c 1 3 140 98 Not Available 11 28 5040 NO EXTERNAL BEAM Not Applicable ADJUVANT Not Available cGy 2010 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO AF Rectum NO Alive 85.4 2010 2009 TCGA-DC-6154 365 Alive T4a N2b M1 Stage IVA 0 365 57 Rectosigmoid Junction TCGA-DC-6154 33e91116-8844-4861-843d-784c70b4a6fc NO Not Available 18 NO 25 -21093 Not Applicable 0 273 Not Available TCGA-DC-6154-D17886;TCGA-DC-6154-D17889;TCGA-DC-6154-D17883;TCGA-DC-6154-D17888 ae7103e5-b431-4be0-b041-09485384352a;ca705d57-a0eb-4310-8628-44af85e60bb9;1535646c-5346-457e-8157-8083e674308f;31ab0762-6f93-45f0-910b-0cc012bfbde4 Not Available;Not Available;Not Available;Not Available 27;27;27;27 242;242;242;242 91;91;91;91 Fluorouracil;Oxaliplatin;Fluorouracil;Leucovorin Not Available;Not Available;Not Available;Not Available 10;10;10;10 12;12;12;12 Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable;Not Applicable 1;1;1;1 IV;IV;IV;IV NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes Not Available;Not Available;Not Available;Ancillary Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available 2011;2011;2011;2011 NOT HISPANIC OR LATINO TCGA-DC-6154-F17762;TCGA-DC-6154-F21437 7da860da-477a-48aa-bc61-3b50676654c3;5c00e450-c8e6-46a0-b0b7-b468f96693dd 25;13 Not Applicable;Not Applicable 273;365 Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available Not Available;Not Available 10;2 NO;NO TUMOR FREE;TUMOR FREE YES;YES Not Available;Not Available NO;NO Alive;Alive 2011;2012 FEMALE 162 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 39 YES Not Available 10 Not Available NO Not Available 0 Not Available 8 Not Available No 6154 YES TUMOR FREE Not Available 16.3 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IVA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M1 N2b T4a NO YES NO DC Rectum YES Alive 59.4 2011 2010 TCGA-EI-6881 499 Alive T3 N1 M0 Stage IIIA 0 499 60 Rectosigmoid Junction TCGA-EI-6881 3aecf83e-c614-4ffa-8c82-1b5dadf6509e NO Not Available 15 NO 17 -22057 Not Applicable 0 188 Not Available TCGA-EI-6881-D29850 b66c7bf1-c626-40ca-b707-a3848b2bdd0b Not Available 30 250 42 5 fluorouracil+leucovorin Not Available 3 6 Not Available mg/m2 ADJUVANT Not Applicable Not Available IV NO Chemotherapy Not Available Not Available mg Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-6881-F29849 f8458cea-739e-40d1-a783-c5b08fe1e40d 30 Not Applicable 499 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE YES Not Available NO Alive 2012 MALE 176 Rectal Adenocarcinoma NO No C20 8263/3 C20.9 YES NO Not Available Not Available NO Not Available 18 NO NO 7 Not Available NO Not Available 0 Not Available 1 Not Available No 6881 NO TUMOR FREE Not Available 60.3 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N1 T3 Not Available YES NO EI Rectum NO Alive 86 2011 2010 TCGA-DY-A1DF 734 Dead T3 N2 M0 Stage IIIC 0 734 73 Rectosigmoid Junction TCGA-DY-A1DF b1a787b6-8e94-4b1b-b063-3338c80eef78 YES Normal Not Available Not Available Not Available -26763 734 0 734 734 NOT HISPANIC OR LATINO FEMALE 156 Rectal Adenocarcinoma Not Available No C19 8140/3 C19.9 YES YES 13 YES Not Available Not Available 15 Not Available NO 5 Not Available Not Available 0 0 5 5 Not Available No A1DF Not Available Not Available Not Available Not Available YES Not Available WHITE Not Available Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N2 T3 NO NO YES DY Rectum Not Available Dead 75 2011 2001 TCGA-AG-A00H 790 Alive T3 N0 M0 Stage IIA 1 790.0 Not Available Unknown 75 Rectum TCGA-AG-A00H 9f4574ec-a58a-4410-8735-c5e5bc4ca7e0 NO Not Available 10 Not Available 15 -27485 Not Applicable 0 29 Not Available TCGA-AG-A00H-D37669 F74BAE20-BD17-4DF8-9A05-AF806FEAA77A Not Available 5 121 90 5-Fluorouracil Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 Not Available TCGA-AG-A00H-F38315 7CBEB7C0-1EC1-4303-BE70-7C210D667199 12 Not Applicable 790 Scheduled Follow-up Submission Progressive Disease NO 12 YES YES Not Available 790 Unknown NO Not Available Not Available YES WITH TUMOR YES Progressive Disease YES Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 32 NO Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available Yes A00H Not Available WITH TUMOR Not Available 1.5 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-A00H-R38355 1390BFF6-8470-476A-A7D3-ED7DCEEFA710 Not Available 13 121 90 Complete Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2011 2008 TCGA-AG-3582 1096 Dead T3 N1 M1 Stage IV 0 1096 75 Rectum TCGA-AG-3582 db1e3104-8bfd-4353-854a-c478ba1f7d07 NO Not Available Not Available Not Available 18 -27636 Not Applicable 0 31 Not Available Not Available TCGA-AG-3582-F37958 A1610969-6DFF-40FE-815E-81B303261EE9 6 1096 Not Available Scheduled Follow-up Submission Unknown NO 12 Unknown Unknown NO Not Available NO Dead 2012 MALE Not Available Rectal Adenocarcinoma NO No C18.9 8140/3 C18.9 YES NO Not Available Not Available NO Not Available 28 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 1 Not Available No 3582 Not Available WITH TUMOR Not Available 612.1 YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M1 N1 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AG-A02N 1885 Alive T3 N0 M0 Stage II 0 1885 67 Rectum TCGA-AG-A02N 8ad1c98b-5395-477e-87a8-19dff3a59c26 NO Not Available Not Available Not Available 15 -24687 Not Applicable 0 1885 Not Available TCGA-AG-A02N-D37687 EB905BAF-E8D7-417B-AA1A-5FA9303ABF20 Not Available 5 89 28 Folinic acid Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 Not Available MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 12 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available No A02N Not Available WITH TUMOR Not Available 2.07 YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-A02N-R38372 C306E25F-03F1-488D-8A9A-72B559B32875 Not Available 13 89 59 Complete Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage II Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum Not Available Alive Not Available 2011 2005 TCGA-AG-3587 1400 Alive T2 N0 M0 Stage I 1 1216.0 Not Available Unknown 65 Rectum TCGA-AG-3587 c9632a8b-dcfe-4480-a8ad-482f55b8cfa2 NO Not Available Not Available Not Available 18 -24075 Not Applicable 0 31 Not Available Not Available TCGA-AG-3587-F37961 C944AE17-F197-4B93-B985-B63FC6463C55 6 Not Applicable 1400 Scheduled Follow-up Submission Unknown NO 12 Unknown Unknown Not Available 1216 Unknown NO Not Available Not Available YES TUMOR FREE NO Unknown YES Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES Not Available Not Available NO NO Not Available 17 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3587 Not Available WITH TUMOR Not Available 1.41 YES Not Available Not Available Not Available Distant Recurrence TCGA-AG-3587-R38351 52A5AD86-5B9F-4198-80CE-BCCAC130C028 Not Available 13 1369 1308 Unknown 12 Not Available 63 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-EI-6514 496 Alive T3 N0 M0 Stage IIA 0 496 59 Sigmoid Colon TCGA-EI-6514 40974ab3-e532-4d6e-9c98-ee640f3976d6 NO Not Available Not Available NO 13 -21618 Not Applicable 0 216 Not Available TCGA-EI-6514-D28631 139796C1-BFC0-4707-9CF2-52A9843422B6 Not Available 27 88 27 5-FU + LEULOV Not Available 2 Not Available Not Available mg ADJUVANT Not Applicable Not Available IV NO Chemotherapy Not Available Not Available Not Available Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-6514-F28630 50212526-646E-40D5-92DD-80EDF761190F 27 Not Applicable 496 Scheduled Follow-up Submission Not Available Not Available 2 NO TUMOR FREE YES Not Available NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C20 8263/3 C20.9 YES NO Not Available Not Available NO Not Available 8 NO Not Available 5 Not Available NO Not Available Not Available Not Available 0 0 No 6514 NO TUMOR FREE Not Available 5.5 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 Not Available YES NO EI Rectum NO Alive Not Available 2011 2010 TCGA-AF-2687 1427 Alive T3 N2 M0 Stage IIIC 1 1267.0 Not Available Unknown 57 Rectum TCGA-AF-2687 f9204a59-6877-4d06-a20e-fd7ab0859ed5 NO Not Available Not Available NO 8 -21098 Not Applicable 0 595 Not Available TCGA-AF-2687-D7471;TCGA-AF-2687-D7475;TCGA-AF-2687-D7476;TCGA-AF-2687-D7474;TCGA-AF-2687-D7473 3041c9c2-446a-4fd8-a6b7-b4ea72dda4fd;e024567d-988f-4c5f-b624-b18ee2d0bc40;0d0a7050-6694-40d7-8087-f5ea54967092;b1351850-ce3f-4280-8c28-f967e6a594a3;66493de1-960a-4d78-abdb-ad820db8bfc4 Not Available;Not Available;Not Available;Not Available;Not Available 9;9;9;9;9 97;259;261;259;259 55;133;133;133;133 Xeloda;5 FU;5 FU;Leucovorin;Oxaliplatin Not Available;Not Available;Not Available;Not Available;Not Available 2;2;2;2;2 Not Available;9;9;9;9 1500;605-684;3629-4104;600-700;129-145 mg;mg;mg;mg;mg ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable 1;2;2;2;2 PO;IV;IV;IV;IV NO;NO;NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy Not Available;Not Available;Not Available;Not Available;Not Available 93,000;5699;34193;5750;1211 mg;mg;mg;mg;mg Not Available;Not Available;Not Available;Not Available;Not Available 2011;2011;2011;2011;2011 NOT HISPANIC OR LATINO TCGA-AF-2687-F7364;TCGA-AF-2687-F10487;TCGA-AF-2687-F40084 51a01fae-9805-48d0-bcb6-843afc405026;dfbfbfb7-e06b-4970-8711-cc78885b37d8;FD8BE15C-49BE-4B72-AAC4-1816B383712D 8;19;13 Not Applicable;Not Applicable;Not Applicable 595;734;1427 Not Available;Not Available;Scheduled Follow-up Submission Not Available;Not Available;Complete Remission/Response Not Available;Not Available;NO 2;4;2 None;None;NO None;None;NO None;None;Not Available None;None;1267 None;None;Unknown None;None;NO None;None;Not Available None;None;Not Available NO;NO;YES TUMOR FREE;TUMOR FREE;TUMOR FREE YES;Not Available;YES Not Available;Not Available;Complete Remission/Response YES;Not Available;YES Alive;Alive;Alive 2011;2011;2013 MALE 163 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available Not Available Not Available 16 YES Not Available 2 Not Available YES Not Available 0 Not Available 6 Not Available No 2687 Not Available TUMOR FREE Not Available 5.3 YES Not Available WHITE Not Available Primary Tumor Field TCGA-AF-2687-R7361 7e39a0da-bc40-44e9-97c5-63bd6ef3d102 1 9 97 56 Not Available 2 28 5040 NO EXTERNAL BEAM Not Applicable ADJUVANT Not Available cGy 2011 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIC Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N2 T3 NO YES NO AF Rectum NO Alive 68.2 2011 2009 TCGA-AG-4005 427 Alive T3 N2 M1 Stage IV 0 427 64 Rectum TCGA-AG-4005 866de12b-e4df-4f19-b62e-e3fd85d4ec08 NO Not Available 6 Not Available 18 -23407 Not Applicable 0 0 Not Available TCGA-AG-4005-D37660;TCGA-AG-4005-D37661;TCGA-AG-4005-D37662 217AFF88-4D43-42A3-9A3E-16D1662C2D28;DB8463A1-4C26-4AC4-9DEE-7392B21B8AA6;380000BA-B2B9-4D32-BA25-4E518DE0341C n/a;n/a;n/a 5;5;5 213;213;213 61;61;61 Folinic acid;5-Fluorouracil;Oxaliplatin Complete Response;Complete Response;Complete Response 12;12;12 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2012;2012;2012 Not Available TCGA-AG-4005-F38310 F203AF61-1DA0-4FFD-9CCE-37CAF0C3A7AB 12 Not Applicable 427 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response NO Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 40 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 7 Not Available No 4005 Not Available WITH TUMOR Not Available 31.52 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M1 N2 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2007 TCGA-EI-6507 607 Alive T3 N0 M0 Stage IIA 0 607 60 Rectum TCGA-EI-6507 c3f0608b-d493-4c74-930a-d7998a48a659 NO Not Available 20 NO 13 -22176 Not Applicable 0 5 Not Available NOT HISPANIC OR LATINO TCGA-EI-6507-F28632 6611f712-ecbc-4158-b32a-3d1b7ee59bd3 27 Not Applicable 607 Scheduled Follow-up Submission Not Available Not Available 2 NO TUMOR FREE NO Not Available NO Alive 2012 MALE 176 Rectal Adenocarcinoma NO No C20 8480/3 C20.9 YES NO Not Available Not Available NO Not Available 25 NO Not Available 9 Not Available NO Not Available 0 Not Available 0 Not Available No 6507 NO TUMOR FREE Not Available 10.7 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO EI Rectum NO Alive 54 2011 2010 TCGA-AG-3902 974 Alive T3 N0 M0 Stage IIA 0 974 61 Rectum TCGA-AG-3902 bcfe4fe9-d090-49f9-85a7-2b472e0f7453 NO Not Available Not Available Not Available 18 -22492 Not Applicable 0 0 Not Available Not Available TCGA-AG-3902-F38023 6CE120F7-F5D0-406E-8039-7A055E83CBAE 8 Not Applicable 974 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 17 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3902 Not Available WITH TUMOR Not Available 8.14 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AF-6672 748 Alive T4a N2b MX Stage IV 1 279.0 Liver Metastatic 43 Rectosigmoid Junction TCGA-AF-6672 6221496d-40cc-4071-969f-6fbcba4f573c NO Not Available Not Available NO 2 -15965 Not Applicable 0 224 Not Available TCGA-AF-6672-D19805;TCGA-AF-6672-D19807;TCGA-AF-6672-D19804;TCGA-AF-6672-D19806 6ff436f2-b6b7-4a69-a1aa-cbc6fe45a89f;dac0f8bc-2057-4165-bc75-9907572612fc;3bf645a0-d4bb-4afe-85e0-bfbe69b64c7e;5d946f3e-2226-4819-bca2-6f6831cae629 Not Available;Not Available;Not Available;Not Available 27;27;27;27 197;199;183;197 43;43;43;43 Leucovorin;Fluorouracil;Oxaliplatin;Fluorouracil Not Available;Not Available;Not Available;Not Available 12;12;12;12 12;12;11;12 50-200;3690-4968;100-176;615-828 mg;mg;mg;mg ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable;Not Applicable 1;1;1;1 IV;IV;IV;IV NO;NO;NO;NO Other, specify in notes;Chemotherapy;Chemotherapy;Chemotherapy Ancillary;Not Available;Not Available;Not Available 1400;51786;1578;8639 mg;mg;mg;mg Not Available;Not Available;Not Available;Not Available 2011;2011;2011;2011 NOT HISPANIC OR LATINO TCGA-AF-6672-F19799;TCGA-AF-6672-F40027 af51da2f-ab70-411f-a7f0-64cfb88801d4;9CC906C8-5B65-4F33-80F9-41A23CAEF708 27;11 Not Applicable;Not Applicable 316;748 Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Progressive Disease Not Available;NO 12;2 NO;YES NO;NO 304;Not Available 279;461 Metastatic;Unknown YES;NO Not Available;Not Available Liver;Not Available YES;YES Not Available;WITH TUMOR YES;YES Not Available;Progressive Disease YES;YES Alive;Alive 2011;2013 MALE 172.7 Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES YES 12 YES NO Not Available 37 YES NO 9 Not Available YES Not Available 0 5 18 Not Available No 6672 Not Available TUMOR FREE Not Available 9.6 YES Not Available WHITE Not Available Primary Tumor Field TCGA-AF-6672-R19800 54ae1baa-4e5e-486e-b157-f6717a579ed2 1 27 185 146 Not Available 12 28 5040 NO EXTERNAL BEAM Not Applicable ADJUVANT Not Available cGy 2011 Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable MX N2b T4a Not Available YES NO AF Rectum NO Alive 93.8 2011 2011 TCGA-AG-3894 426 Alive T3 N0 M0 Stage IIA 0 426 65 Rectum TCGA-AG-3894 065b26fc-6827-44d5-83d8-1100c63fcda6 NO Not Available Not Available Not Available 18 -23954 Not Applicable 0 30 Not Available TCGA-AG-3894-D37655 E4102A2F-8A6F-4B7C-9E20-3970FC3DD124 Not Available 5 245 61 5-Fluorouracil Complete Response 12 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 Not Available TCGA-AG-3894-F38020 2022E30D-185C-4BF5-8602-17AAFAED7CC6 8 Not Applicable 426 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE YES Complete Remission/Response YES Alive 2012 MALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 15 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3894 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available Primary Tumor Field TCGA-AG-3894-R38360 1D19B143-2456-4A5D-AE81-53C9D60E422D Not Available 13 92 61 Complete Response 12 Not Available 50 NO External Not Applicable Not Available Not Available Gy 2012 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum YES Alive Not Available 2010 2009 TCGA-AF-2692 412 Alive T3 N0 M0 Stage IIA 1 327.0 Other Metastatic 54 Not Available TCGA-AF-2692 71a32fca-d48f-4ea3-8df7-69f9dda8fa91 NO Not Available Not Available YES 10 -19830 Not Applicable 0 412 Not Available TCGA-AF-2692-D9921 8d16b3a4-228c-430e-a26c-6747b843381d Not Available 21 384 344 Xeloda Not Available 12 Not Available 1500 mg RECURRENCE Not Applicable 1 PO NO Chemotherapy Not Available 87000 mg Not Available 2010 NOT HISPANIC OR LATINO TCGA-AF-2692-F10351 d6a1d481-8e01-4139-9d11-7f3b23f130c1 10 Not Applicable 412 Not Available Not Available Not Available 11 YES YES 396 327 Metastatic YES R0 Other YES WITH TUMOR NO Not Available NO Alive 2010 FEMALE 170 Not Available NO No C20 8140/3 C20.9 YES YES 12 YES NO Not Available 12 NO Not Available 11 Not Available NO Not Available 0 Not Available 0 Not Available No 2692 Not Available WITH TUMOR Not Available 10.6 YES Not Available WHITE Not Available Primary Tumor Field;Distant site TCGA-AF-2692-R9920;TCGA-AF-2692-R9918 94bd837c-1105-4e0c-b84c-b5392c7ebc8b;3839f8d1-df50-44f5-aec2-31597910f245 1;1 21;21 385;435 350;418 Not Available;Not Available 12;12 25;14 5000;3500 NO;NO EXTERNAL BEAM;EXTERNAL BEAM Not Applicable;Not Applicable RECURRENCE;PALLIATIVE Not Available;Not Available cGy;cGy 2010;2010 R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO AF Not Available NO Alive 64.4 2010 2009 TCGA-AF-4110 912 Alive T4a N2b MX Stage IVA 0 912 77 Rectosigmoid Junction TCGA-AF-4110 5f10f8e4-a6f9-4643-b210-390bc8fd32bd NO Not Available Not Available YES 6 -28289 Not Applicable 0 441 Not Available TCGA-AF-4110-D13658;TCGA-AF-4110-D13664;TCGA-AF-4110-D13665;TCGA-AF-4110-D13666 8e82086a-6e5b-4fd9-b884-c08049426228;0916a9a1-c34b-4f5f-82d9-bd1d903c605e;ea9270b1-82ca-4900-a127-946f0ec99902;cbc1140c-d519-4b62-90fa-5fe35623fa70 Not Available;Not Available;Not Available;Not Available 7;7;7;7 261;261;261;263 65;65;65;65 Oxaliplatin;5FU;Leucovorin;5FU Not Available;Not Available;Not Available;Not Available 7;7;7;7 9;9;9;9 185;875;500-875;5200 mg;mg;mg;mg ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT Not Applicable;Not Applicable;Not Applicable;Not Applicable 1;1;1;1 IV;IV;IV;IV NO;NO;NO;NO Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy Not Available;Not Available;Leucovorin;Not Available 1665;7875;5875;46800 mg;mg;mg;mg Not Available;Not Available;Not Available;Not Available 2011;2011;2011;2011 NOT HISPANIC OR LATINO TCGA-AF-4110-F13614;TCGA-AF-4110-F40320 e5cd0dc2-47f4-4c84-a6a7-49decdbd76e3;CA7ADA59-E99E-4F3C-88C9-6E30E422FDBA 7;15 Not Applicable;Not Applicable 441;912 Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Complete Remission/Response Not Available;NO 7;2 NO;NO TUMOR FREE;TUMOR FREE YES;YES Not Available;Complete Remission/Response NO;NO Alive;Alive 2011;2013 MALE 188 Not Available NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 34 YES NO 7 Not Available YES 0 0 5 21 Not Available No 4110 Not Available TUMOR FREE Not Available 28.7 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IVA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable MX N2b T4a NO YES NO AF Not Available YES Alive 92 2011 2010 TCGA-EI-6511 482 Alive T3 N1 M0 Stage IIIB 0 482 52 Rectum TCGA-EI-6511 d004a083-6dc6-4db6-96d0-88a8ca3b1b93 NO Not Available Not Available YES 9 -19237 Not Applicable 0 121 Not Available TCGA-EI-6511-D28932 CA39B724-0291-4EB0-87A1-D85C280C3964 Not Available 2 182 161 oxaliplatinum+5-FU Not Available 3 3 Not Available mg/m2/day ADJUVANT Not Applicable Not Available IV NO Chemotherapy Not Available Not Available mg Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-6511-F28930 E798707B-0F2C-4F9A-BA35-032DDF99D55D 2 Not Applicable 482 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE YES Not Available YES Alive 2012 MALE 165 Rectal Adenocarcinoma NO No C20 8263/3 C20.9 YES NO Not Available Not Available Not Available Not Available 18 YES Not Available 6 Not Available NO Not Available Not Available Not Available 4 Not Available No 6511 YES TUMOR FREE Not Available 14.9 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1 T3 Not Available YES NO EI Rectum NO Alive 69 2011 2010 TCGA-DY-A1DE 3932 Alive T3 N0 M0 Stage IIA 1 3316.0 Not Available Unknown 56 Rectum TCGA-DY-A1DE 5555fbdd-962f-4d79-b36c-ae3c3cc4aff4 YES Normal Not Available Not Available Not Available -20504 Not Applicable 0 3667 3667 TCGA-DY-A1DE-D30446;TCGA-DY-A1DE-D30447 D369621F-ABAD-4DC9-B8ED-BAC84CF0BFB5;2B357047-E9A9-473A-9D6C-0DFD7D0DE8C8 Not Available;Not Available 10;10 78;379 46;291 Mayo 425-20;Mayo 425-20 Complete Response;Complete Response 4;4 Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Available;Not Available Not Applicable;Not Applicable Not Available;Not Available Not Available;Not Available NO;NO Chemotherapy;Chemotherapy Not Available;Not Available Not Available;Not Available Not Available;Not Available NO;NO 2012;2012 NOT HISPANIC OR LATINO TCGA-DY-A1DE-F19046 EB9A942F-CF37-4E8D-98D9-791973F9D383 5 Not Applicable 3932 Scheduled Follow-up Submission Not Available Not Available 12 Not Available Not Available Not Available 3316 Unknown NO Not Available Not Available YES Not Available Not Available Not Available Not Available Alive 2011 FEMALE 160 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES YES 61 YES Not Available Not Available 14 NO NO 5 Not Available Not Available 0 0 5 0 Not Available No A1DE Not Available Not Available Not Available Not Available YES Not Available WHITE Not Available Primary Tumor Field TCGA-DY-A1DE-R30540 D500ADD4-8062-4D6A-B9B6-10509272BC16 Not Available 12 174 75 Not Available 4 Not Available Not Available NO Not Available Not Applicable ADJUVANT Not Available Not Available 2012 Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES DY Rectum NO Alive 70 2011 2001 TCGA-DC-6682 762 Alive T3 N0 M0 Stage IIA 0 762 57 Rectosigmoid Junction TCGA-DC-6682 26964b56-583f-46cc-ab2e-a948bf3e5432 NO Not Available 45 NO Not Available -21062 Not Applicable 0 122 Not Available NOT HISPANIC OR LATINO TCGA-DC-6682-F15649;TCGA-DC-6682-F30873;TCGA-DC-6682-F44769 b62802e1-65da-4682-913b-a28b0f2c7e33;e6b4da6e-5734-4424-89a7-ee9a84543bdf;791588E2-F159-47E4-B4E2-7A65CD7BF924 Not Available;17;26 Not Applicable;Not Applicable;Not Applicable 122;397;762 Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Not Available;Not Applicable Not Available;Not Available;NO 8;4;6 NO;NO;NO TUMOR FREE;TUMOR FREE;TUMOR FREE NO;NO;NO Not Available;Not Available;Not Applicable NO;NO;NO Alive;Alive;Alive 2011;2012;2013 MALE 184 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 24 NO Not Available 8 Not Available NO Not Available 0 Not Available 0 Not Available No 6682 NO TUMOR FREE Not Available 13.8 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO DC Rectum NO Alive 172.4 2011 2011 TCGA-AG-3586 31 Alive T3 N2 M0 Stage III 0 31 72 Rectum TCGA-AG-3586 a8b974f4-aabf-484d-bfa2-a286b39681e0 NO Not Available Not Available Not Available 18 -26542 Not Applicable 0 31 Not Available Not Available FEMALE Not Available Not Available NO No C19 8480/3 C19.9 YES NO Not Available Not Available NO Not Available 19 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 4 Not Available No 3586 Not Available WITH TUMOR Not Available 1.86 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage III Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M0 N2 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2006 TCGA-EI-6508 636 Alive T3 N1a M0 Stage IIIB 0 636 48 Rectosigmoid Junction TCGA-EI-6508 d8bfcc67-f5c3-42cd-9fc4-bd483f896da1 NO Not Available 12 NO 9 -17827 Not Applicable 0 66 Not Available TCGA-EI-6508-D28936 a4922b17-c151-4bac-bd9d-a607e43949e8 Not Available 2 258 76 oxaliplatinum + 5-FU Not Available 3 12 Not Available mg/m2/day ADJUVANT Not Applicable Not Available IV NO Chemotherapy Not Available Not Available mg Not Available 2012 NOT HISPANIC OR LATINO TCGA-EI-6508-F28935 e969163b-56cb-49f1-a9a4-3a8b44fd676d 1 Not Applicable 636 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE YES Not Available NO Alive 2012 FEMALE 159 Rectal Adenocarcinoma Not Available No C20 8263/3 C20.9 YES NO Not Available Not Available Not Available Not Available 15 YES Not Available 6 Not Available NO Not Available 1 Not Available 1 Not Available No 6508 YES TUMOR FREE Not Available 0.6 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIB Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1a T3 Not Available YES NO EI Rectum NO Alive 66 2011 2010 TCGA-F5-6571 1288 Alive T3 N0 M0 Stage IIA 1 122.0 Liver Metastatic 62 Rectum TCGA-F5-6571 85947797-54b8-44fb-910b-5cd689542994 NO Not Available Not Available NO 23 -22666 Not Applicable 0 26 Not Available TCGA-F5-6571-D29834;TCGA-F5-6571-D53525;TCGA-F5-6571-D53527;TCGA-F5-6571-D53530;TCGA-F5-6571-D53531;TCGA-F5-6571-D65905;TCGA-F5-6571-D65907;TCGA-F5-6571-D65909;TCGA-F5-6571-D65922;TCGA-F5-6571-D65923;TCGA-F5-6571-D65924 857CE230-D7C1-4EC3-A8E3-327337A6A5CD;2B9D27E5-E361-4657-8DA6-21B9D8454DFD;2F82A9D7-83B1-4A8F-9EC8-D81BDCBF24B4;08406C00-17CA-42E1-BB5F-919DD9BE7FD8;E3940B66-3CF4-4484-A360-2A1E70F345EB;AF8F3EF6-1533-41EA-9E07-49767EF773FB;752ADA80-5EDC-4F56-AEF4-F64C81591C01;EB1AB997-77FB-4F19-A8CE-2B4F475F4548;BFAF1A47-D8B9-4307-AB33-423277F0B8F8;55F67205-87D7-49DF-85D4-77DBA50B9A0A;82FA8F68-90F5-42E8-8ABF-5A8C488D0F1E Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available 29;12;12;12;12;1;1;1;1;1;1 350;813;952;952;952;1157;1157;1157;Not Available;Not Available;Not Available 226;770;847;847;847;1065;1065;1065;1065;1255;1255 Capecitabine;Mitomycin;5-Fluorouracil;Leucovorin;Oxaliplatin;Irinotecan;Leucovorin;5-Fluorouracil;Bevacizumab;Oxaliplatin;Gemcitabine Not Available;Clinical Progressive Disease;Complete Response;Complete Response;Complete Response;Stable Disease;Stable Disease;Stable Disease;Not Applicable;Not Applicable;Not Applicable 3;12;12;12;12;10;10;10;10;10;10 6;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available 4;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available g/day;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available RECURRENCE;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available PO;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available NO;NO;NO;NO;NO;NO;NO;NO;YES;YES;YES Chemotherapy;Chemotherapy;Chemotherapy;Ancillary;Chemotherapy;Chemotherapy;Ancillary;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available 336;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available g/day;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available Not Available;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO 2012;2013;2013;2013;2013;2014;2014;2014;2014;2014;2014 NOT HISPANIC OR LATINO TCGA-F5-6571-F29833;TCGA-F5-6571-F53522;TCGA-F5-6571-F53534 2A3B4B12-541A-47F4-A361-7F76C73DF422;B35975A1-4FAD-466A-88DD-3B8E83AE96FB;A2043FB3-CF3D-4C8A-86F7-B8395DCA9B03 29;12;12 Not Applicable;Not Applicable;Not Applicable 392;952;1288 Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Complete Remission/Response;Stable Disease Not Available;NO;NO 3;12;12 YES;YES;YES NO;NO;NO 150;Not Available;Not Available 122;660;1059 Metastatic;Unknown;Unknown YES;NO;NO RX;Not Available;Not Available Liver;Liver;Liver YES;YES;YES TUMOR FREE;TUMOR FREE;WITH TUMOR NO;NO;NO Not Available;Complete Remission/Response;Complete Remission/Response NO;NO;NO Alive;Alive;Alive 2012;2013;2013 FEMALE 166 Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 2 NO Not Available 8 Not Available NO Not Available Not Available Not Available 0 0 No 6571 NO TUMOR FREE Not Available Not Available YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO F5 Rectum NO Alive 80 2011 2011 TCGA-AG-3892 396 Alive T1 N0 M0 Stage I 0 396 57 Rectum TCGA-AG-3892 ded3feb2-1079-4520-a7ca-f5b5fc73d7c5 NO Not Available Not Available Not Available 18 -20880 Not Applicable 0 31 Not Available Not Available TCGA-AG-3892-F38018 C50631C8-CD29-4443-970B-3AB492922E7E 8 Not Applicable 396 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Complete Remission/Response NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 17 Not Available Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3892 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T1 NO NO YES AG Rectum Not Available Alive Not Available 2010 2009 TCGA-EI-6882 262 Alive T3 N0 M0 Stage IIA 0 262 59 Rectosigmoid Junction TCGA-EI-6882 e3a80e41-2e46-4b04-86c6-fd444d616ab5 NO Not Available 30 NO 18 -21682 Not Applicable 0 108 Not Available NOT HISPANIC OR LATINO TCGA-EI-6882-F29848 35b07b0e-99b9-45a3-a2e1-b9b38802029b 26 Not Applicable 262 Scheduled Follow-up Submission Not Available Not Available 3 NO TUMOR FREE NO Not Available NO Alive 2012 MALE 178 Rectal Mucinous Adenocarcinoma NO No C20 8255/3 C20.9 YES NO Not Available Not Available NO Not Available 21 NO NO 7 Not Available NO Not Available 0 Not Available 0 Not Available No 6882 NO TUMOR FREE Not Available 1.3 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO YES NO EI Rectum NO Alive 108 2011 2011 TCGA-AG-3598 1522 Alive T3 N0 M0 Stage IIA 0 1522 69 Rectum TCGA-AG-3598 6bc056f2-f06e-428f-aebc-85b780d880ed NO Not Available Not Available Not Available 18 -25324 Not Applicable 0 0 Not Available Not Available TCGA-AG-3598-F37968 D179A4FD-195C-4D8B-A694-CAFA7C21BCBF 6 Not Applicable 1522 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available NO Not Available 65 NO Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3598 Not Available WITH TUMOR Not Available 4.76 YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AG Rectum NO Alive Not Available 2010 2007 TCGA-AG-3891 548 Alive T2 N0 M0 Stage I 0 548 66 Rectum TCGA-AG-3891 d461e83a-7f09-4e4c-ac49-f05766a6051a NO Not Available Not Available Not Available 18 -24411 Not Applicable 0 30 Not Available Not Available TCGA-AG-3891-F38017 55926AA9-64C6-41AA-9E9C-0A5B1893A549 8 Not Applicable 548 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Not Available NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 13 YES Not Available 5 Not Available Not Available Not Available 0 Not Available 0 Not Available No 3891 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum Not Available Alive Not Available 2010 2009 TCGA-AG-A008 424 Alive T2 N0 M0 Stage I 0 424 50 Rectum TCGA-AG-A008 e7503a51-6647-4cc2-80dd-645d0df4db43 NO Not Available Not Available Not Available 15 -18416 Not Applicable 0 0 Not Available Not Available TCGA-AG-A008-F38306 DC1D0381-ED7B-4C3C-9EED-323B032E6057 12 Not Applicable 424 Scheduled Follow-up Submission Complete Remission/Response NO 12 NO TUMOR FREE NO Complete Remission/Response NO Alive 2012 FEMALE Not Available Rectal Mucinous Adenocarcinoma YES No C20 8480/3 C20.9 YES NO Not Available Not Available NO Not Available 28 NO Not Available 6 Not Available Not Available Not Available 0 Not Available 0 Not Available No A008 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T2 NO NO YES AG Rectum NO Alive Not Available 2011 2009 TCGA-AF-2689 1201 Dead T3 N2 M1 Stage IV 1 301.0 Not Available Unknown 41 Rectosigmoid Junction TCGA-AF-2689 335d0351-3740-4847-9ff4-be2f078c70f7 NO Not Available Not Available NO 5 -15082 Not Applicable 0 482 Not Available TCGA-AF-2689-D2997;TCGA-AF-2689-D3030;TCGA-AF-2689-D3028;TCGA-AF-2689-D3029;TCGA-AF-2689-D2996;TCGA-AF-2689-D3001;TCGA-AF-2689-D3007;TCGA-AF-2689-D2991;TCGA-AF-2689-D2998;TCGA-AF-2689-D3024;TCGA-AF-2689-D3308;TCGA-AF-2689-D3309;TCGA-AF-2689-D3307;TCGA-AF-2689-D4053 8675aae4-8055-487a-b80a-4e53c4629f87;22e444fa-7135-4389-bad0-7f7bcdc45420;4d891da7-ccc2-4b3e-b531-0bbd6385e6a6;1dcab074-5ee4-4818-89bf-d7fdd9de8818;772bc81b-8c06-48f0-a915-68df8ceba7eb;6dd36a05-450e-45a0-b0c5-579a3b63651b;bf52814b-2808-468b-9ae6-49608c492c80;5ae8e910-5b3a-4fb0-8bd2-f37b9756c396;0cd90c9e-bd4f-4cbf-ad1d-dd6d457912e7;e843e98b-59be-4d00-b606-7eaf5e9d9ac7;8c673e37-976e-454d-841d-a0888f2d93ed;7eefebc0-11fd-4028-87c6-cab921f47ab3;5df65b50-c401-4ff5-af88-293a113e284a;62a137f0-ba1f-4bfa-a6cc-cfe749a79ca4 Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available 5;5;5;5;5;5;5;5;5;5;12;12;12;24 267;346;344;344;267;269;344;239;267;344;559;559;559;559 85;316;316;316;85;85;316;85;85;316;379;462;379;379 Oxaliplatin;5FU;Leucovorin;5FU;Leucovorin;5FU;Aflibercept/ Placebo Study;Bevacizumab;5FU;Irinotecan;Camptosar;Avastin;FUDR (Floxuridine);Leucovorin Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available 11;11;11;11;11;11;11;11;11;11;11;11;11;11 11;3;3;3;12;12;3;10;12;3;Not Available;Not Available;Not Available;Not Available 50-129;3408-3456;568-576;568-576;600;3480-3648;175-180;229.5 - 259.1;580-608;256-259;330-430;500-515;1135-1500;710-760 mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg PALLIATIVE;PROGRESSION;PROGRESSION;PROGRESSION;PALLIATIVE;PALLIATIVE;PROGRESSION;PALLIATIVE;PALLIATIVE;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable 1;1;1;1;1;1;1;1;1;1;2;2;2;2 IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO Chemotherapy;Chemotherapy;Other, specify in notes;Other, specify in notes;Chemotherapy;Other, specify in notes;Other, specify in notes;Chemotherapy;Other, specify in notes;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Other, specify in notes Not Available;Velour 10262 Study- Aflibercept/Placebo (4mg/kg) every 2 weeks with Irinotecan/5FU Combination (FOLFIRI);Other Ancillary-Velour 10262 Study- Aflibercept/Placebo (4mg/kg) every 2 weeks with Irinotecan/5FU Combination (FOLFIRI);Velour 10262 Study- Aflibercept/Placebo (4mg/kg) every 2 weeks with Irinotecan/5FU Combination (FOLFIRI);Ancillary;Not Available;Velour 10262 Study- Aflibercept/Placebo (4mg/kg) every 2 weeks with Irinotecan/5FU Combination (FOLFIRI);Not Available;Not Available;Velour 10262 Study- Aflibercept/Placebo (4mg/kg) every 2 weeks with Irinotecan/5FU Combination (FOLFIRI);Not Available;Not Available;Not Available;Ancillary 707;10296;1716;1716;7200;42192;537;2363.5;7032;772;Not Available;Not Available;Not Available;Not Available mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available 2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010 NOT HISPANIC OR LATINO TCGA-AF-2689-F3299;TCGA-AF-2689-F34683;TCGA-AF-2689-F34721;TCGA-AF-2689-F34761 67b84c68-c27f-4cca-9a78-97f170fe362a;6062AC06-4371-495B-A7AB-B59EB997DEE2;30BF5D9D-16C0-4348-A146-D06C856FD8FB;836C3D65-5AD5-41BB-9BE8-5D3B9CF0024C 12;28;30;30 Not Applicable;1201;1201;1201 546;Not Available;Not Available;Not Available Not Available;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event Not Available;Progressive Disease;Progressive Disease;Progressive Disease Not Available;NO;NO;NO 11;8;8;8 YES;YES;NO;NO NO;NO;NO;NO Not Available;Not Available;Not Available;Not Available 301;461;1134;1134 Unknown;Unknown;Unknown;Unknown NO;NO;NO;NO Not Available;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available YES;YES;YES;YES WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR YES;Not Available;Not Available;Not Available Not Available;Not Available;Not Available;Not Available NO;Not Available;Not Available;Not Available Alive;Dead;Dead;Dead 2010;2012;2012;2012 FEMALE 163 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES YES 13 YES NO Not Available 32 YES Not Available 11 Not Available NO Not Available Not Available Not Available 6 Not Available No 2689 Not Available WITH TUMOR Not Available 6.0 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M1 N2 T3 NO YES NO AF Rectum NO Alive 55.5 2010 2009 TCGA-AG-A016 276 Alive T3 N2 M1 Stage IV 0 276 55 Rectum TCGA-AG-A016 9c7b5e85-5579-4d0f-a7ea-b9d081ac0037 NO Not Available Not Available Not Available 15 -20178 Not Applicable 0 31 Not Available TCGA-AG-A016-D37670;TCGA-AG-A016-D37671;TCGA-AG-A016-D37672 D17DDE62-D61E-4DC5-B0BD-069B51F864DC;078B47FD-21FB-4FD2-8F32-E9DD57433938;A029C8B8-87C1-462D-B804-E918A20290E6 n/a;n/a;n/a 5;5;5 245;61;245 31;31;61 5-Fluorouracil;Folinic acid;Bevacizumab Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease 12;12;12 Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Applicable;Not Applicable;Not Applicable Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO Chemotherapy;Chemotherapy;Targeted Molecular therapy Not Available;Not Available;Not Available Not Available;Not Available;Not Available Not Available;Not Available;Not Available NO;NO;NO 2012;2012;2012 Not Available TCGA-AG-A016-F38512 2E9CA8A0-0B0B-4B40-88F8-AE3D2B4010FD 16 Not Applicable 276 Scheduled Follow-up Submission Progressive Disease NO 12 NO WITH TUMOR YES Progressive Disease NO Alive 2012 MALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 19 YES Not Available 6 Not Available Not Available Not Available 0 Not Available 4 Not Available No A016 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M1 N2 T3 NO NO YES AG Rectum NO Alive Not Available 2011 2009 TCGA-DY-A1DC 1258 Dead T3 N0 M0 Stage IIA 1 630.0 Not Applicable Locoregional Disease 72 Rectosigmoid Junction TCGA-DY-A1DC 205f30ff-fb10-44a8-a1c6-c538de100db5 YES Normal Not Available Not Available Not Available -26436 1258 0 Not Available Not Available TCGA-DY-A1DC-D30402 1DD51FDD-A9D3-4ECD-B3DF-F74DABB7F28D Not Available 10 828 771 Capecitabine -xeloda Partial Response 4 Not Available Not Available Not Available Not Available Not Applicable Not Available Not Available NO Chemotherapy Not Available Not Available Not Available NO 2012 NOT HISPANIC OR LATINO TCGA-DY-A1DC-F19043 FD4A2C05-AD6E-44F9-8FCC-7F7A2021A946 2 1258 Not Available Scheduled Follow-up Submission Not Available Not Available 12 Not Available YES 818 630 Locoregional Disease YES Not Available Not Applicable YES Not Available Not Available Not Available Not Available Dead 2011 FEMALE Not Available Rectal Adenocarcinoma Not Available No C19 8140/3 C19.9 YES YES Not Available NO Not Available Not Available 16 NO NO 5 Not Available Not Available 0 Not Available 5 0 Not Available No A1DC Not Available Not Available Not Available Not Available YES Not Available WHITE Not Available Primary Tumor Field TCGA-DY-A1DC-R30532 19D4160B-CB4B-4F90-9B09-F2A04B4E88AB Not Available 12 169 128 Not Available 4 Not Available Not Available NO Not Available Not Applicable ADJUVANT Not Available Not Available 2012 Not Available Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable Not Available Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES DY Rectum NO Dead 68 2011 2000 TCGA-AF-A56K 2635 Alive T3 N0 M0 Stage IIA 1 1217.0 Not Applicable Locoregional Disease 56 Sigmoid Colon TCGA-AF-A56K BD818AE4-B31A-4616-9303-B8AEE56A848F NO Not Available 0 NO 18 -20527 Not Applicable 0 2396 Not Available NOT HISPANIC OR LATINO TCGA-AF-A56K-F51084 49EF5BDD-8904-4FB6-ABA5-E17D5074611B 7 Not Applicable 2635 Scheduled Follow-up Submission Complete Remission/Response NO 11 NO TUMOR FREE NO Complete Remission/Response NO Alive 2013 MALE 182.5 Rectal Adenocarcinoma NO No C19 8140/3 C19.9 YES NO Not Available Not Available Not Available Not Available 44 NO Unknown 4 YES YES 1458 1217 Locoregional Disease YES R1 Not Applicable YES NO Not Available 0 Not Available 0 Not Available No A56K Unknown TUMOR FREE NO 0.5 YES Complete Remission/Response BLACK OR AFRICAN AMERICAN NO R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIA Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T3 NO NO YES AF Rectum NO Alive 145.5 2013 2006 TCGA-AF-6655 609 Alive T2 N1 M0 Stage IIIA 0 609 66 Rectum TCGA-AF-6655 ce2e0f1c-60ff-4f93-8bba-4f4d3ccac37c NO Not Available Not Available NO 15 -24417 Not Applicable 0 194 Not Available NOT HISPANIC OR LATINO TCGA-AF-6655-F19775;TCGA-AF-6655-F39414 5926098b-3927-4026-92ba-6ea25afdda4c;B3B69DDC-12FE-4DCD-826A-C2E517F69848 23;22 Not Applicable;Not Applicable 355;609 Scheduled Follow-up Submission;Scheduled Follow-up Submission Not Available;Complete Remission/Response Not Available;NO 12;1 NO;NO TUMOR FREE;TUMOR FREE NO;NO Not Available;Complete Remission/Response NO;NO Alive;Alive 2011;2013 MALE 173 Rectal Adenocarcinoma YES No C19 8140/3 C19.9 YES NO Not Available Not Available YES MLH1-Expressed;MSH2-Expressed;PMS2-Expressed;MSH6-Expressed 29 YES NO 8 Not Available NO 0 0 4 2 Not Available No 6655 Not Available TUMOR FREE Not Available 1.6 YES Not Available WHITE Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IIIA Not Applicable Not Applicable Not Applicable 7th Not Applicable Not Applicable Not Applicable M0 N1 T2 NO YES NO AF Rectum NO Alive 53.2 2011 2010 TCGA-AG-A023 1581 Dead T4 N2 M1 Stage IV 1 822.0 Not Available Unknown 62 Rectum TCGA-AG-A023 3bc6e336-f58e-4dc4-8414-7318e55016ed NO Not Available Not Available Not Available 15 -22830 Not Applicable 0 61 Not Available Not Available TCGA-AG-A023-F38514 22A4EA99-88E0-4117-9F6A-46BEE8B92076 16 1581 Not Available Scheduled Follow-up Submission Progressive Disease NO 12 Unknown Unknown Not Available 822 Unknown NO Not Available Not Available YES WITH TUMOR NO Not Available NO Dead 2012 FEMALE Not Available Rectal Adenocarcinoma NO No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 12 YES Not Available 6 Not Available Not Available Not Available 1 Not Available 6 Not Available Yes A023 Not Available WITH TUMOR Not Available 1.88 YES Not Available Not Available Not Available R2 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage IV Not Applicable Not Applicable Not Applicable 5th Not Applicable Not Applicable Not Applicable M1 N2 T4 NO NO YES AG Rectum YES Alive Not Available 2011 2005 TCGA-AG-A015 1096 Alive T1 N0 M0 Stage I 1 518.0 Not Available Unknown 64 Rectum TCGA-AG-A015 09daff79-6493-45c1-8cba-9381259e2bea NO Not Available Not Available Not Available 15 -23496 Not Applicable 0 0 Not Available Not Available TCGA-AG-A015-F38511 929B4674-D970-476F-9968-D98282FC031B 16 Not Applicable 1096 Scheduled Follow-up Submission Complete Remission/Response NO 12 Unknown Unknown Not Available 518 Unknown NO Not Available Not Available YES TUMOR FREE NO Not Available NO Alive 2012 FEMALE Not Available Rectal Adenocarcinoma YES No C20 8140/3 C20.9 YES NO Not Available Not Available NO Not Available 18 NO Not Available 6 Not Available Not Available Not Available 1 Not Available 0 Not Available Yes A015 Not Available WITH TUMOR Not Available Not Available YES Not Available Not Available Not Available R0 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Stage I Not Applicable Not Applicable Not Applicable 6th Not Applicable Not Applicable Not Applicable M0 N0 T1 NO NO YES AG Rectum NO Alive Not Available 2011 2009